| Year |
Citation |
Score |
| 2024 |
Zanti M, O'Mahony DG, Parsons MT, Dorling L, Dennis J, Boddicker NJ, Chen W, Hu C, Naven M, Yiangou K, Ahearn TU, Ambrosone CB, Andrulis IL, Antoniou AC, Auer PL, et al. Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classification. Medrxiv : the Preprint Server For Health Sciences. PMID 39281752 DOI: 10.1101/2024.09.04.24313051 |
0.314 |
|
| 2024 |
McDonald JA, Liao Y, Knight JA, John EM, Kurian AW, Daly M, Buys SS, Huang Y, Frost CJ, Andrulis IL, Colonna SV, Friedlander ML, Hopper JL, Chung WK, Genkinger JM, et al. Pregnancy-Related Factors and Breast Cancer Risk for Women Across a Range of Familial Risk. Jama Network Open. 7: e2427441. PMID 39186276 DOI: 10.1001/jamanetworkopen.2024.27441 |
0.329 |
|
| 2024 |
Davidson AL, Michailidou K, Parsons MT, Fortuno C, Bolla MK, Wang Q, Dennis J, Naven M, Abubakar M, Ahearn TU, Alonso MR, Andrulis IL, Antoniou AC, Auvinen P, Behrens S, et al. Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset. American Journal of Human Genetics. PMID 39096911 DOI: 10.1016/j.ajhg.2024.07.004 |
0.389 |
|
| 2024 |
Yiangou K, Mavaddat N, Dennis J, Zanti M, Wang Q, Bolla MK, Abubakar M, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baten A, et al. Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction. Medrxiv : the Preprint Server For Health Sciences. PMID 38410445 DOI: 10.1101/2024.02.12.24302043 |
0.33 |
|
| 2023 |
Wichert K, Hoppe R, Ickstadt K, Behrens T, Winter S, Herold R, Terschüren C, Lo WY, Guénel P, Truong T, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, ... Andrulis IL, et al. Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer. European Journal of Epidemiology. 38: 1053-1068. PMID 37789226 DOI: 10.1007/s10654-023-01048-7 |
0.324 |
|
| 2023 |
Middha P, Wang X, Behrens S, Bolla MK, Wang Q, Dennis J, Michailidou K, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, Baert T, et al. A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry. Breast Cancer Research : Bcr. 25: 93. PMID 37559094 DOI: 10.1186/s13058-023-01691-8 |
0.365 |
|
| 2023 |
Levi H, Carmi S, Rosset S, Yerushalmi R, Zick A, Yablonski-Peretz T, Wang Q, Bolla MK, Dennis J, Michailidou K, Lush M, Ahearn T, Andrulis IL, Anton-Culver H, Antoniou AC, et al. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel. Journal of Medical Genetics. PMID 37451831 DOI: 10.1136/jmg-2023-109185 |
0.35 |
|
| 2023 |
Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, Adank MA, Ahearn TU, Antonenkova NN, Auvinen P, Behrens S, Bermisheva M, Bogdanova NV, Bojesen SE, ... ... Andrulis IL, et al. Spectrum and Frequency of Germline Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases. Cancers. 15. PMID 37444426 DOI: 10.3390/cancers15133313 |
0.381 |
|
| 2023 |
Morra A, Schreurs MAC, Andrulis IL, Anton-Culver H, Augustinsson A, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brauch H, Broeks A, Buys SS, Camp NJ, Castelao JE, Cessna MH, et al. Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival. Cancer Medicine. PMID 37401034 DOI: 10.1002/cam4.6272 |
0.41 |
|
| 2023 |
Kast K, John EM, Hopper JL, Andrieu N, Noguès C, Mouret-Fourme E, Lasset C, Fricker JP, Berthet P, Mari V, Salle L, Schmidt MK, Ausems MGEM, Garcia EBG, van de Beek I, ... ... Andrulis IL, et al. Associations of height, body mass index, and weight gain with breast cancer risk in carriers of a pathogenic variant in BRCA1 or BRCA2: the BRCA1 and BRCA2 Cohort Consortium. Breast Cancer Research : Bcr. 25: 72. PMID 37340476 DOI: 10.1186/s13058-023-01673-w |
0.358 |
|
| 2023 |
Muranen TA, Morra A, Khan S, Barnes DR, Bolla MK, Dennis J, Keeman R, Leslie G, Parsons MT, Wang Q, Ahearn TU, Aittomäki K, Andrulis IL, Arun BK, Behrens S, et al. PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants. Npj Breast Cancer. 9: 37. PMID 37173335 DOI: 10.1038/s41523-023-00546-x |
0.415 |
|
| 2023 |
Morra A, Mavaddat N, Muranen TA, Ahearn TU, Allen J, Andrulis IL, Auvinen P, Becher H, Behrens S, Blomqvist C, Bojesen SE, Bolla MK, Brauch H, Camp NJ, Carvalho S, et al. The impact of coding germline variants on contralateral breast cancer risk and survival. American Journal of Human Genetics. PMID 36827971 DOI: 10.1016/j.ajhg.2023.02.003 |
0.424 |
|
| 2023 |
Figlioli G, Billaud A, Ahearn TU, Antonenkova NN, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Blok MJ, Bogdanova NV, Bonanni B, Burwinkel B, Camp NJ, Campbell A, ... ... Andrulis IL, et al. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. European Journal of Human Genetics : Ejhg. PMID 36707629 DOI: 10.1038/s41431-022-01257-w |
0.425 |
|
| 2023 |
Mueller SH, Lai AG, Valkovskaya M, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Abu-Ful Z, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, et al. Aggregation tests identify new gene associations with breast cancer in populations with diverse ancestry. Genome Medicine. 15: 7. PMID 36703164 DOI: 10.1186/s13073-022-01152-5 |
0.372 |
|
| 2023 |
Lopes Cardozo JMN, Andrulis IL, Bojesen SE, Dörk T, Eccles DM, Fasching PA, Hooning MJ, Keeman R, Nevanlinna H, Rutgers EJT, Easton DF, Hall P, Pharoah PDP, van 't Veer LJ, Schmidt MK. Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2201978. PMID 36689693 DOI: 10.1200/JCO.22.01978 |
0.439 |
|
| 2022 |
Haslam DE, John EM, Knight JA, Li Z, Buys SS, Andrulis IL, Daly MB, Genkinger JM, Terry MB, Zhang FF. Diet Quality and All-Cause Mortality in Women with Breast Cancer from the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36857773 DOI: 10.1158/1055-9965.EPI-22-1198 |
0.315 |
|
| 2022 |
Dixon-Suen SC, Lewis SJ, Martin RM, English DR, Boyle T, Giles GG, Michailidou K, Bolla MK, Wang Q, Dennis J, Lush M, Investigators A, Ahearn TU, Ambrosone CB, Andrulis IL, et al. Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. British Journal of Sports Medicine. 56: 1157-1170. PMID 36328784 DOI: 10.1136/bjsports-2021-105132 |
0.363 |
|
| 2022 |
Li H, Engel C, Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, Radice P, Thomassen M, Hansen TVO, Gerdes AM, Nielsen HR, Caputo SM, Zambelli A, Borg A, Solano A, ... ... Andrulis IL, et al. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 24: 2208. PMID 36205748 DOI: 10.1016/j.gim.2022.08.005 |
0.405 |
|
| 2022 |
Hakkaart C, Pearson JF, Marquart L, Dennis J, Wiggins GAR, Barnes DR, Robinson BA, Mace PD, Aittomäki K, Andrulis IL, Arun BK, Azzollini J, Balmaña J, Barkardottir RB, Belhadj S, et al. Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology. 5: 1061. PMID 36203093 DOI: 10.1038/s42003-022-03978-6 |
0.429 |
|
| 2022 |
Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, Fasching PA, Abubakar M, Andrulis IL, Anton-Culver H, Beckmann MW, Blomqvist C, Bojesen SE, Bolla MK, Bonanni B, et al. Incorporating progesterone receptor expression into the PREDICT breast prognostic model. European Journal of Cancer (Oxford, England : 1990). 173: 178-193. PMID 35933885 DOI: 10.1016/j.ejca.2022.06.011 |
0.31 |
|
| 2022 |
Dumont M, Weber-Lassalle N, Joly-Beauparlant C, Ernst C, Droit A, Feng BJ, Dubois S, Collin-Deschesnes AC, Soucy P, Vallée M, Fournier F, Lemaçon A, Adank MA, Allen J, Altmüller J, ... ... Andrulis IL, et al. Uncovering the Contribution of Moderate-Penetrance Susceptibility Genes to Breast Cancer by Whole-Exome Sequencing and Targeted Enrichment Sequencing of Candidate Genes in Women of European Ancestry. Cancers. 14. PMID 35884425 DOI: 10.3390/cancers14143363 |
0.41 |
|
| 2022 |
Geczik AM, Ferris JS, Terry MB, Andrulis IL, Buys SS, Daly MB, Hopper JL, John EM, Kurian AW, Southey MC, Liao Y, Genkinger JM. Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations. Breast Cancer Research and Treatment. PMID 35780210 DOI: 10.1007/s10549-022-06656-7 |
0.381 |
|
| 2022 |
Jennings C, Wynn J, Miguel C, Levinson E, Florido ME, White M, Sands CB, Schwartz LA, Daly M, O'Toole K, Buys SS, Glendon G, Hanna D, Andrulis IL, Terry MB, et al. Mother and Daughter Perspectives on Genetic Counseling and Testing of Adolescents for Hereditary Breast Cancer Risk. The Journal of Pediatrics. PMID 35777474 DOI: 10.1016/j.jpeds.2022.06.027 |
0.307 |
|
| 2022 |
Goldberg M, McDonald JA, Houghton LC, Andrulis IL, Knight JA, Bradbury AR, Schwartz LA, Buys SS, Frost CJ, Daly MB, John EM, Keegan THM, Chung WK, Wei Y, Terry MB. Maternal and prenatal factors and age at thelarche in the LEGACY Girls Study cohort: implications for breast cancer risk. International Journal of Epidemiology. PMID 35613015 DOI: 10.1093/ije/dyac108 |
0.419 |
|
| 2022 |
Dorling L, Carvalho S, Allen J, Parsons MT, Fortuno C, González-Neira A, Heijl SM, Adank MA, Ahearn TU, Andrulis IL, Auvinen P, Becher H, Beckmann MW, Behrens S, Bermisheva M, et al. Breast cancer risks associated with missense variants in breast cancer susceptibility genes. Genome Medicine. 14: 51. PMID 35585550 DOI: 10.1186/s13073-022-01052-8 |
0.437 |
|
| 2022 |
Wang X, Kapoor PM, Auer PL, Dennis J, Dunning AM, Wang Q, Lush M, Michailidou K, Bolla MK, Aronson KJ, Murphy RA, Brooks-Wilson A, Lee DG, Cordina-Duverger E, Guénel P, ... ... Andrulis IL, et al. Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women. Scientific Reports. 12: 6199. PMID 35418701 DOI: 10.1038/s41598-022-10121-2 |
0.329 |
|
| 2022 |
Mavaddat N, Dorling L, Carvalho S, Allen J, González-Neira A, Keeman R, Bolla MK, Dennis J, Wang Q, Ahearn TU, Andrulis IL, Beckmann MW, Behrens S, Benitez J, et al. Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes. Jama Oncology. PMID 35084436 DOI: 10.1001/jamaoncol.2021.6744 |
0.429 |
|
| 2022 |
Li S, Silvestri V, Leslie G, Rebbeck TR, Neuhausen SL, Hopper JL, Nielsen HR, Lee A, Yang X, McGuffog L, Parsons MT, Andrulis IL, Arnold N, Belotti M, Borg Å, et al. Cancer Risks Associated With and Pathogenic Variants. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2102112. PMID 35077220 DOI: 10.1200/JCO.21.02112 |
0.343 |
|
| 2022 |
Dennis J, Tyrer JP, Walker LC, Michailidou K, Dorling L, Bolla MK, Wang Q, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Freeman LEB, Beckmann MW, et al. Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology. 5: 65. PMID 35042965 DOI: 10.1038/s42003-021-02990-6 |
0.404 |
|
| 2022 |
Ahearn TU, Zhang H, Michailidou K, Milne RL, Bolla MK, Dennis J, Dunning AM, Lush M, Wang Q, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Auer PL, Augustinsson A, et al. Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research : Bcr. 24: 2. PMID 34983606 DOI: 10.1186/s13058-021-01484-x |
0.4 |
|
| 2021 |
Kehm RD, MacInnis RJ, John EM, Liao Y, Kurian AW, Genkinger JM, Knight JA, Colonna SV, Chung WK, Milne R, Zeinomar N, Dite GS, Southey MC, Giles GG, McLachlan SA, ... ... Andrulis IL, et al. Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk. Jnci Cancer Spectrum. 5: pkab090. PMID 34950851 DOI: 10.1093/jncics/pkab090 |
0.329 |
|
| 2021 |
Li H, Engel C, de la Hoya M, Peterlongo P, Yannoukakos D, Livraghi L, Radice P, Thomassen M, Hansen TVO, Gerdes AM, Nielsen HR, Caputo SM, Zambelli A, Borg A, Solano A, ... ... Andrulis IL, et al. Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 34906479 DOI: 10.1016/j.gim.2021.08.016 |
0.369 |
|
| 2021 |
Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, et al. Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research : Bcr. 23: 86. PMID 34407845 DOI: 10.1186/s13058-021-01450-7 |
0.41 |
|
| 2021 |
Park HA, Neumeyer S, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Baten A, Beane Freeman LE, et al. Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer. PMID 34341517 DOI: 10.1038/s41416-021-01432-8 |
0.323 |
|
| 2021 |
Barnes DR, Silvestri V, Leslie G, McGuffog L, Dennis J, Yang X, Adlard J, Agnarsson BA, Ahmed M, Aittomäki K, Andrulis IL, Arason A, Arnold N, Auber B, Azzollini J, et al. Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores. Journal of the National Cancer Institute. PMID 34320204 DOI: 10.1093/jnci/djab147 |
0.349 |
|
| 2021 |
Choi YH, Jung H, Buys S, Daly M, John EM, Hopper J, Andrulis I, Terry MB, Briollais L. A competing risks model with binary time varying covariates for estimation of breast cancer risks in families. Statistical Methods in Medical Research. 9622802211008945. PMID 34232831 DOI: 10.1177/09622802211008945 |
0.407 |
|
| 2021 |
Brooks JD, Nabi HH, Andrulis IL, Antoniou AC, Chiquette J, Després P, Devilee P, Dorval M, Droit A, Easton DF, Eisen A, Eloy L, Fienberg S, Goldgar D, Hahnen E, et al. Personalized Risk Assessment for Prevention and Early Detection of Breast Cancer: Integration and Implementation (PERSPECTIVE I&I). Journal of Personalized Medicine. 11. PMID 34199804 DOI: 10.3390/jpm11060511 |
0.322 |
|
| 2021 |
Baxter JS, Johnson N, Tomczyk K, Gillespie A, Maguire S, Brough R, Fachal L, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, et al. Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. American Journal of Human Genetics. PMID 34146516 DOI: 10.1016/j.ajhg.2021.05.013 |
0.319 |
|
| 2021 |
Lakeman IMM, van den Broek AJ, Vos JAM, Barnes DR, Adlard J, Andrulis IL, Arason A, Arnold N, Arun BK, Balmaña J, Barrowdale D, Benitez J, Borg A, Caldés T, Caligo MA, et al. The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 34113011 DOI: 10.1038/s41436-021-01198-7 |
0.408 |
|
| 2021 |
Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, Noh DY, Ahn SH, Lee JW, Kim MK, Jee SH, Wen W, Bolla MK, Wang Q, ... ... Andrulis IL, et al. Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? Cancers. 13. PMID 34069208 DOI: 10.3390/cancers13102370 |
0.412 |
|
| 2021 |
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, et al. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 2986. PMID 33990587 DOI: 10.1038/s41467-021-23162-4 |
0.406 |
|
| 2021 |
Li N, Zethoven M, McInerny S, Devereux L, Huang YK, Thio N, Cheasley D, Gutiérrez-Enríquez S, Moles-Fernández A, Diez O, Nguyen-Dumont T, Southey MC, Hopper JL, Simard J, Dumont M, ... ... Andrulis IL, et al. Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects. Npj Breast Cancer. 7: 52. PMID 33980861 DOI: 10.1038/s41523-021-00255-3 |
0.483 |
|
| 2021 |
Choi YH, Terry MB, Daly MB, MacInnis RJ, Hopper JL, Colonna S, Buys SS, Andrulis IL, John EM, Kurian AW, Briollais L. Association of Risk-Reducing Salpingo-Oophorectomy With Breast Cancer Risk in Women With BRCA1 and BRCA2 Pathogenic Variants. Jama Oncology. PMID 33630024 DOI: 10.1001/jamaoncol.2020.7995 |
0.371 |
|
| 2021 |
Coignard J, Lush M, Beesley J, O'Mara TA, Dennis J, Tyrer JP, Barnes DR, McGuffog L, Leslie G, Bolla MK, Adank MA, Agata S, Ahearn T, Aittomäki K, Andrulis IL, et al. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers. Nature Communications. 12: 1078. PMID 33597508 DOI: 10.1038/s41467-020-20496-3 |
0.394 |
|
| 2021 |
Johnson N, Maguire S, Morra A, Kapoor PM, Tomczyk K, Jones ME, Schoemaker MJ, Gilham C, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, et al. CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer. PMID 33495599 DOI: 10.1038/s41416-020-01185-w |
0.405 |
|
| 2021 |
Dorling L, Carvalho S, Allen J, González-Neira A, Luccarini C, Wahlström C, Pooley KA, Parsons MT, Fortuno C, Wang Q, Bolla MK, Dennis J, Keeman R, Alonso MR, ... ... Andrulis IL, et al. Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. The New England Journal of Medicine. PMID 33471991 DOI: 10.1056/NEJMoa1913948 |
0.418 |
|
| 2020 |
MacInnis RJ, Knight JA, Chung WK, Milne RL, Whittemore AS, Buchsbaum R, Liao Y, Zeinomar N, Dite GS, Southey MC, Goldgar D, Giles GG, Kurian AW, Andrulis IL, et al. Comparing Five-Year and Lifetime Risks of Breast Cancer in the Prospective Family Study Cohort. Journal of the National Cancer Institute. PMID 33301022 DOI: 10.1093/jnci/djaa178 |
0.343 |
|
| 2020 |
Kramer I, Hooning MJ, Mavaddat N, Hauptmann M, Keeman R, Steyerberg EW, Giardiello D, Antoniou AC, Pharoah PDP, Canisius S, Abu-Ful Z, Andrulis IL, Anton-Culver H, Aronson KJ, Augustinsson A, et al. Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. American Journal of Human Genetics. PMID 33022221 DOI: 10.1016/j.ajhg.2020.09.001 |
0.392 |
|
| 2020 |
Muranen TA, Khan S, Fagerholm R, Aittomäki K, Cunningham JM, Dennis J, Leslie G, McGuffog L, Parsons MT, Simard J, Slager S, Soucy P, Easton DF, Tischkowitz M, Spurdle AB, ... ... Andrulis IL, et al. Association of germline variation with the survival of women with pathogenic variants and breast cancer. Npj Breast Cancer. 6: 44. PMID 32964118 DOI: 10.1038/s41523-020-00185-6 |
0.409 |
|
| 2020 |
Barnes DR, Rookus MA, McGuffog L, Leslie G, Mooij TM, Dennis J, Mavaddat N, Adlard J, Ahmed M, Aittomäki K, Andrieu N, Andrulis IL, Arnold N, Arun BK, Azzollini J, et al. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 32665703 DOI: 10.1038/S41436-020-0862-X |
0.399 |
|
| 2020 |
Silvestri V, Leslie G, Barnes DR, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Barkardottir RB, Barroso A, Barrowdale D, Benitez J, Bonanni B, Borg A, Buys SS, et al. Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Jama Oncology. PMID 32614418 DOI: 10.1001/Jamaoncol.2020.2134 |
0.35 |
|
| 2020 |
Liu J, Prager-van der Smissen WJC, Collée JM, Bolla MK, Wang Q, Michailidou K, Dennis J, Ahearn TU, Aittomäki K, Ambrosone CB, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Arnold N, et al. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. 10: 9688. PMID 32546843 DOI: 10.1038/S41598-020-65665-Y |
0.477 |
|
| 2020 |
Zhang H, Ahearn TU, Lecarpentier J, Barnes D, Beesley J, Qi G, Jiang X, O'Mara TA, Zhao N, Bolla MK, Dunning AM, Dennis J, Wang Q, Ful ZA, Aittomäki K, ... Andrulis IL, et al. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses. Nature Genetics. PMID 32424353 DOI: 10.1038/s41588-020-0609-2 |
0.439 |
|
| 2020 |
Kapoor PM, Mavaddat N, Choudhury PP, Wilcox AN, Lindström S, Behrens S, Michailidou K, Dennis J, Bolla MK, Wang Q, Jung A, Abu-Ful Z, Ahearn T, Andrulis IL, Anton-Culver H, et al. Combined associations of a polygenic risk score and classical risk factors with breast cancer risk. Journal of the National Cancer Institute. PMID 32359158 DOI: 10.1093/Jnci/Djaa056 |
0.361 |
|
| 2020 |
Feng H, Gusev A, Pasaniuc B, Wu L, Long J, Abu-Full Z, Aittomäki K, Andrulis IL, Anton-Culver H, Antoniou AC, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, et al. Transcriptome-wide association study of breast cancer risk by estrogen-receptor status. Genetic Epidemiology. PMID 32115800 DOI: 10.1002/gepi.22288 |
0.431 |
|
| 2020 |
Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA, Noguès C, Gauthier-Villars M, Caron O, Gesta P, Pujol P, Lortholary A, Barrowdale D, Frost D, ... ... Andrulis IL, et al. Correction to: Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 22: 25. PMID 32102695 DOI: 10.1186/S13058-020-01259-W |
0.391 |
|
| 2020 |
Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, Auvinen P, Beckmann MW, Beesley J, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Blot W, et al. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nature Communications. 11: 312. PMID 31949161 DOI: 10.1038/S41467-019-14100-6 |
0.411 |
|
| 2020 |
Mavaddat N, Antoniou AC, Mooij TM, Hooning MJ, Heemskerk-Gerritsen BA, Noguès C, Gauthier-Villars M, Caron O, Gesta P, Pujol P, Lortholary A, Barrowdale D, Frost D, ... ... Andrulis IL, et al. Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 22: 8. PMID 31948486 DOI: 10.1186/S13058-020-1247-4 |
0.413 |
|
| 2020 |
Fachal L, Aschard H, Beesley J, Barnes DR, Allen J, Kar S, Pooley KA, Dennis J, Michailidou K, Turman C, Soucy P, Lemaçon A, Lush M, Tyrer JP, Ghoussaini M, ... ... Andrulis IL, et al. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics. PMID 31911677 DOI: 10.1038/s41588-019-0537-1 |
0.303 |
|
| 2019 |
Phillips KA, Liao Y, Milne RL, MacInnis RJ, Collins IM, Buchsbaum R, Weideman PC, Bickerstaffe A, Nesci S, Chung WK, Southey MC, Knight JA, Whittemore AS, Dite GS, Goldgar D, ... ... Andrulis IL, et al. Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool. Jnci Cancer Spectrum. 3: pkz066. PMID 31853515 DOI: 10.1093/Jncics/Pkz066 |
0.319 |
|
| 2019 |
Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, ... ... Andrulis IL, et al. Cancer Risks Associated With Germline Pathogenic Variants: An International Study of 524 Families. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901907. PMID 31841383 DOI: 10.1200/Jco.19.01907 |
0.365 |
|
| 2019 |
Li H, Terry MB, Antoniou AC, Phillips KA, Kast K, Mooij TM, Engel C, Noguès C, Stoppa-Lyonnet D, Lasset C, Berthet P, Mari V, Caron O, Barrowdale D, Frost D, ... ... Andrulis IL, et al. Alcohol consumption, cigarette smoking, and risk of breast cancer for BRCA1 and BRCA2 mutation carriers: results from The BRCA1 and BRCA2 Cohort Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31792088 DOI: 10.1158/1055-9965.Epi-19-0546 |
0.364 |
|
| 2019 |
Figlioli G, Bogliolo M, Catucci I, Caleca L, Lasheras SV, Pujol R, Kiiski JI, Muranen TA, Barnes DR, Dennis J, Michailidou K, Bolla MK, Leslie G, Aalfs CM, ... ... Andrulis IL, et al. The :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer. Npj Breast Cancer. 5: 38. PMID 31700994 DOI: 10.1038/s41523-019-0127-5 |
0.45 |
|
| 2019 |
MacInnis RJ, Liao Y, Knight JA, Milne RL, Whittemore AS, Chung WK, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Southey MC, Goldgar D, Giles GG, McLachlan SA, Weideman PC, ... ... Andrulis IL, et al. Considerations when using breast cancer risk models for women with negative BRCA1/BRCA2 mutation results. Journal of the National Cancer Institute. PMID 31584660 DOI: 10.1093/Jnci/Djz194 |
0.414 |
|
| 2019 |
Kehm RD, Genkinger JM, MacInnis RJ, John EM, Phillips KA, Dite GS, Milne RL, Zeinomar N, Liao Y, Knight JA, Southey MC, Chung WK, Giles GG, McLachlan SA, Whitaker KD, ... ... Andrulis IL, et al. Recreational physical activity is associated with reduced breast cancer risk in adult women at high risk for breast cancer: a cohort study of women selected for familial and genetic risk. Cancer Research. PMID 31578201 DOI: 10.1158/0008-5472.Can-19-1847 |
0.395 |
|
| 2019 |
Dörk T, Peterlongo P, Mannermaa A, Bolla MK, Wang Q, Dennis J, Ahearn T, Andrulis IL, Anton-Culver H, Arndt V, Aronson KJ, Augustinsson A, Freeman LEB, Beckmann MW, Beeghly-Fadiel A, et al. Two truncating variants in FANCC and breast cancer risk. Scientific Reports. 9: 12524. PMID 31467304 DOI: 10.1038/s41598-019-48804-y |
0.476 |
|
| 2019 |
Shu X, Bao J, Wu L, Long J, Shu XO, Guo X, Yang Y, Michailidou K, Bolla MK, Wang Q, Dennis J, Andrulis IL, Castelao JE, Dörk T, Gago-Dominguez M, et al. Evaluation of Associations between Genetically Predicted Circulating Protein Biomarkers and Breast Cancer Risk. International Journal of Cancer. PMID 31265136 DOI: 10.1002/Ijc.32542 |
0.398 |
|
| 2019 |
Yang Y, Wu L, Shu XO, Cai Q, Shu X, Li B, Guo X, Ye F, Michailidou K, Bolla MK, Wang Q, Dennis J, Andrulis IL, Brenner H, Chenevix-Trench G, et al. Genetically predicted levels of DNA methylation biomarkers and breast cancer risk: data from 228,951 women of European descent. Journal of the National Cancer Institute. PMID 31143935 DOI: 10.1093/Jnci/Djz109 |
0.363 |
|
| 2019 |
Kehm RD, Hopper JL, John EM, Phillips KA, MacInnis RJ, Dite GS, Milne RL, Liao Y, Zeinomar N, Knight JA, Southey MC, Vahdat L, Kornhauser N, Cigler T, Chung WK, ... ... Andrulis IL, et al. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study. Breast Cancer Research : Bcr. 21: 52. PMID 30999962 DOI: 10.1186/S13058-019-1135-Y |
0.391 |
|
| 2019 |
Ferreira MA, Gamazon ER, Al-Ejeh F, Aittomäki K, Andrulis IL, Anton-Culver H, Arason A, Arndt V, Aronson KJ, Arun BK, Asseryanis E, Azzollini J, Balmaña J, Barnes DR, Barrowdale D, et al. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer. Nature Communications. 10: 1741. PMID 30988301 DOI: 10.1038/s41467-018-08053-5 |
0.435 |
|
| 2019 |
Terry MB, Liao Y, Whittemore AS, Leoce N, Buchsbaum R, Zeinomar N, Dite GS, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, McLachlan SA, Friedlander ML, ... ... Andrulis IL, et al. 10-year performance of four models of breast cancer risk: a validation study. The Lancet. Oncology. PMID 30799262 DOI: 10.1016/S1470-2045(18)30902-1 |
0.369 |
|
| 2019 |
Houghton LC, Knight JA, Wei Y, Romeo RD, Goldberg M, Andrulis IL, Bradbury AR, Buys SS, Daly MB, John EM, Chung WK, Santella RM, Stanczyk FZ, Terry MB. Association of Prepubertal and Adolescent Androgen Concentrations With Timing of Breast Development and Family History of Breast Cancer. Jama Network Open. 2: e190083. PMID 30794303 DOI: 10.1001/jamanetworkopen.2019.0083 |
0.403 |
|
| 2019 |
Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, et al. Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer. PMID 30787463 DOI: 10.1038/S41416-019-0393-X |
0.362 |
|
| 2019 |
Kar SP, Andrulis IL, Brenner H, Burgess S, Chang-Claude J, Considine D, Dörk T, Evans DGR, Gago-Domínguez M, Giles GG, Hartman M, Huo D, Kaaks R, Li J, Lophatananon A, et al. The association between weight at birth and breast cancer risk revisited using Mendelian randomisation. European Journal of Epidemiology. PMID 30737679 DOI: 10.1007/S10654-019-00485-7 |
0.385 |
|
| 2019 |
Zeinomar N, Phillips KA, Daly MB, Milne RL, Dite GS, MacInnis RJ, Liao Y, Kehm RD, Knight JA, Southey MC, Chung WK, Giles GG, McLachlan SA, Friedlander ML, Weideman PC, ... ... Andrulis IL, et al. Benign Breast Disease Increases Breast Cancer Risk Independent of Underlying Familial Risk Profile: Findings from a Prospective Family Study Cohort (ProF-SC). International Journal of Cancer. PMID 30725480 DOI: 10.1002/Ijc.32112 |
0.317 |
|
| 2019 |
Jiang X, Finucane HK, Schumacher FR, Schmit SL, Tyrer JP, Han Y, Michailidou K, Lesseur C, Kuchenbaecker KB, Dennis J, Conti DV, Casey G, Gaudet MM, Huyghe JR, Albanes D, ... ... Andrulis IL, et al. Shared heritability and functional enrichment across six solid cancers. Nature Communications. 10: 431. PMID 30683880 DOI: 10.1038/S41467-018-08054-4 |
0.348 |
|
| 2019 |
Phillips K, Liao Y, Collins I, Buchsbaum R, Weideman P, Bickerstaffe A, MacInnis R, Cuzick J, Antoniou A, Andrulis I, John E, Daly M, Buys S, Hopper J, Terry M. Validation of iPrevent using the prospective family study cohort (ProF-SC) Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-09-02 |
0.387 |
|
| 2018 |
Terry MB, Liao Y, Kast K, Antoniou AC, McDonald JA, Mooij TM, Engel C, Nogues C, Buecher B, Mari V, Moretta-Serra J, Gladieff L, Luporsi E, Barrowdale D, Frost D, ... ... Andrulis IL, et al. The Influence of Number and Timing of Pregnancies on Breast Cancer Risk for Women With or Mutations. Jnci Cancer Spectrum. 2: pky078. PMID 30873510 DOI: 10.1093/Jncics/Pky078 |
0.344 |
|
| 2018 |
Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, ... Andrulis IL, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics. PMID 30554720 DOI: 10.1016/J.Ajhg.2018.11.002 |
0.377 |
|
| 2018 |
Terry MB, Daly MB, Phillips KA, Ma X, Zeinomar N, Leoce N, Dite GS, MacInnis RJ, Chung WK, Knight JA, Southey MC, Milne RL, Goldgar D, Giles GG, Weideman PC, ... ... Andrulis IL, et al. Risk-Reducing Oophorectomy and Breast Cancer Risk Across the Spectrum of Familial Risk. Journal of the National Cancer Institute. PMID 30496449 DOI: 10.1093/Jnci/Djy182 |
0.415 |
|
| 2018 |
Hopper JL, Dite GS, MacInnis RJ, Liao Y, Zeinomar N, Knight JA, Southey MC, Milne RL, Chung WK, Giles GG, Genkinger JM, McLachlan SA, Friedlander ML, Antoniou AC, Weideman PC, ... ... Andrulis IL, et al. Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC). Breast Cancer Research : Bcr. 20: 132. PMID 30390716 DOI: 10.1186/S13058-018-1056-1 |
0.312 |
|
| 2018 |
Qian F, Wang S, Mitchell J, McGuffog L, Barrowdale D, Leslie G, Oosterwijk JC, Chung WK, Evans DG, Engel C, Kast K, Aalfs CM, Adank MA, Adlard J, Agnarsson BA, ... ... Andrulis IL, et al. Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. Journal of the National Cancer Institute. PMID 30312457 DOI: 10.1093/jnci/djy132 |
0.413 |
|
| 2018 |
Walker LC, Marquart L, Pearson JF, Wiggins GAR, O'Mara TA, Parsons MT, Barrowdale D, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D, ... ... Andrulis IL, et al. Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. European Journal of Human Genetics : Ejhg. PMID 30135485 DOI: 10.1038/s41431-018-0216-1 |
0.35 |
|
| 2018 |
Lee M, Tayyari F, Pinnaduwage D, Bayani J, Bartlett JMS, Mulligan AM, Bull SB, Andrulis IL. Tumoral BRD4 expression in lymph node-negative breast cancer: association with T-bet+ tumor-infiltrating lymphocytes and disease-free survival. Bmc Cancer. 18: 750. PMID 30029633 DOI: 10.1186/S12885-018-4653-6 |
0.345 |
|
| 2018 |
Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al-Ejeh F, Rozali E, Wang Q, Dennis J, Li B, ... ... Andrulis IL, et al. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nature Genetics. PMID 29915430 DOI: 10.1038/S41588-018-0132-X |
0.432 |
|
| 2018 |
Scannell Bryan M, Argos M, Andrulis IL, Hopper JL, Chang-Claude J, Malone KE, John EM, Gammon MD, Daly MB, Terry MB, Buys SS, Huo D, Olopade OI, Genkinger JM, Whittemore AS, et al. Germline variation and breast cancer incidence: A gene-based association study and whole-genome prediction of early onset breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29898891 DOI: 10.1158/1055-9965.Epi-17-1185 |
0.411 |
|
| 2018 |
Dougan MM, Li Y, Chu LW, Haile RW, Whittemore AS, Han SS, Moore SC, Sampson JN, Andrulis IL, John EM, Hsing AW. Metabolomic profiles in breast cancer:a pilot case-control study in the breast cancer family registry. Bmc Cancer. 18: 532. PMID 29728083 DOI: 10.1186/S12885-018-4437-Z |
0.382 |
|
| 2018 |
Pande M, Joon A, Brewster AM, Chen WV, Hopper JL, Eng C, Shete S, Casey G, Schumacher F, Lin Y, Harrison TA, White E, Ahsan H, Andrulis IL, Whittemore AS, et al. Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies. Plos One. 13: e0196245. PMID 29698419 DOI: 10.1371/Journal.Pone.0196245 |
0.433 |
|
| 2018 |
Houghton LC, Knight JA, De Souza MJ, Goldberg M, White ML, O'Toole K, Chung WK, Bradbury AR, Daly MB, Andrulis IL, John EM, Buys SS, Terry MB. Comparison of methods to assess onset of breast development in the LEGACY Girls Study: methodological considerations for studies of breast cancer. Breast Cancer Research : Bcr. 20: 33. PMID 29669587 DOI: 10.1186/S13058-018-0943-9 |
0.387 |
|
| 2018 |
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, ... ... Andrulis IL, et al. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications. 9: 16193. PMID 29633761 DOI: 10.1038/Ncomms16193 |
0.335 |
|
| 2018 |
Colombo M, Lòpez-Perolio I, Meeks HD, Caleca L, Parsons M, Li H, De Vecchi G, Tudini E, Foglia C, Mondini P, Manoukian S, Behar R, Garcia EBG, Meindl A, Montagna M, ... ... Andrulis IL, et al. The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity. Human Mutation. PMID 29460995 DOI: 10.1002/humu.23411 |
0.311 |
|
| 2018 |
Wu HC, Do C, Andrulis IL, John EM, Daly MB, Buys SS, Chung WK, Knight JA, Bradbury AR, Keegan THM, Schwartz L, Krupska I, Miller RL, Santella RM, Tycko B, et al. Breast Cancer Family History and Allele-Specific DNA Methylation in the Legacy Girls Study. Epigenetics. 1-23. PMID 29436922 DOI: 10.1080/15592294.2018.1435243 |
0.341 |
|
| 2018 |
Lu C, Jain S, Hoelper D, Bechet D, Ran L, Andrulis I, Dickson B, Majewski J, Thompson C, Chi P, Garcia B, Jabado N, Lewis P, Allis CD. Abstract PR12: Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Sarcomas17-Pr12 |
0.335 |
|
| 2018 |
Zeinomar N, Phillips K, Liao Y, MacInnis R, Dite G, Daly M, John E, Andrulis I, Buys S, Hopper J, Terry M. Abstract P6-09-04: Benign breast disease and breast cancer risk across the spectrum of familial risk using a prospective family study cohort (ProF-SC) Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-09-04 |
0.499 |
|
| 2018 |
Terry M, Phillips K, Daly M, Andrulis I, Liao Y, Ma X, Zeinomar N, MacInnis R, Dite G, John E, Buys S, Hopper J. Abstract P6-09-01: Risk-reducing oophorectomy and breast cancer risk across the spectrum of familial risk using a prospective family study cohort (ProF-SC) Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-09-01 |
0.417 |
|
| 2017 |
Jiao X, Aravidis C, Marikkannu R, Rantala J, Picelli S, Adamovic T, Liu T, Maguire P, Kremeyer B, Luo L, von Holst S, Kontham V, Thutkawkorapin J, Margolin S, Du Q, ... ... Andrulis IL, et al. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. Oncotarget. 8: 102769-102782. PMID 29262523 DOI: 10.18632/Oncotarget.21800 |
0.388 |
|
| 2017 |
Guo Q, Burgess S, Turman C, Bolla MK, Wang Q, Lush M, Abraham J, Aittomäki K, Andrulis IL, Apicella C, Arndt V, Barrdahl M, Benitez J, Berg CD, Blomqvist C, et al. Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology. 46: 1814-1822. PMID 29232439 DOI: 10.1093/Ije/Dyx131 |
0.352 |
|
| 2017 |
Brouckaert O, Rudolph A, Laenen A, Keeman R, Bolla MK, Wang Q, Soubry A, Wildiers H, Andrulis IL, Arndt V, Beckmann MW, Benitez J, Blomqvist C, Bojesen SE, Brauch H, et al. Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Research : Bcr. 19: 119. PMID 29116004 DOI: 10.1186/S13058-017-0909-3 |
0.391 |
|
| 2017 |
Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, ... ... Andrulis IL, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. PMID 29059683 DOI: 10.1038/Nature24284 |
0.439 |
|
| 2017 |
Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, ... ... Andrulis IL, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. PMID 29058716 DOI: 10.1038/Ng.3785 |
0.452 |
|
| 2017 |
Li J, Li H, Makunin I, Thompson BA, Tao K, Young EL, Lopez J, Camp NJ, Tavtigian SV, John EM, Andrulis IL, Khanna KK, Goldgar D, Chenevix-Trench G. Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families. Breast Cancer Research and Treatment. PMID 28840378 DOI: 10.1007/S10549-017-4469-0 |
0.437 |
|
| 2017 |
Kuchenbaecker KB, Hopper JL, Barnes DR, Phillips KA, Mooij TM, Roos-Blom MJ, Jervis S, van Leeuwen FE, Milne RL, Andrieu N, Goldgar DE, Terry MB, Rookus MA, Easton DF, Antoniou AC, ... ... Andrulis IL, et al. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers. Jama. 317: 2402-2416. PMID 28632866 DOI: 10.1001/Jama.2017.7112 |
0.44 |
|
| 2017 |
Terry MB, Keegan THM, Houghton LC, Goldberg M, Andrulis IL, Daly MB, Buys SS, Wei Y, Whittemore AS, Protacio A, Bradbury AR, Chung WK, Knight JA, John EM. Pubertal development in girls by breast cancer family history: the LEGACY girls cohort. Breast Cancer Research : Bcr. 19: 69. PMID 28595647 DOI: 10.1186/S13058-017-0849-Y |
0.408 |
|
| 2017 |
Scannell Bryan M, Argos M, Andrulis IL, Hopper JL, Chang-Claude J, Malone K, John EM, Gammon MD, Daly M, Terry MB, Buys SS, Huo D, Olopade O, Genkinger JM, Jasmine F, et al. Limited influence of germline genetic variation on all-cause mortality in women with early onset breast cancer: evidence from gene-based tests, single-marker regression, and whole-genome prediction. Breast Cancer Research and Treatment. PMID 28503721 DOI: 10.1007/S10549-017-4287-4 |
0.369 |
|
| 2017 |
Lecarpentier J, Silvestri V, Kuchenbaecker KB, Barrowdale D, Dennis J, McGuffog L, Soucy P, Leslie G, Rizzolo P, Navazio AS, Valentini V, Zelli V, Lee A, Amin Al Olama A, Tyrer JP, ... ... Andrulis IL, et al. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016694935. PMID 28448241 DOI: 10.1200/Jco.2016.69.4935 |
0.392 |
|
| 2017 |
Day FR, Thompson DJ, Helgason H, Chasman DI, Finucane H, Sulem P, Ruth KS, Whalen S, Sarkar AK, Albrecht E, Altmaier E, Amini M, Barbieri CM, Boutin T, Campbell A, ... ... Andrulis IL, et al. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nature Genetics. PMID 28436984 DOI: 10.1038/Ng.3841 |
0.312 |
|
| 2017 |
Shimelis H, Mesman RL, Von Nicolai C, Ehlen A, Guidugli L, Martin C, Calleja FM, Meeks H, Hallberg E, Hinton J, Lilyquist J, Hu C, Aalfs CM, Aittomaki K, Andrulis IL, et al. BRCA2 hypomorphic missense variants confer moderate risks of breast cancer. Cancer Research. PMID 28283652 DOI: 10.1158/0008-5472.Can-16-2568 |
0.521 |
|
| 2017 |
Zhang FF, Haslam DE, Terry MB, Knight JA, Andrulis IL, Daly MB, Buys SS, John EM. Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry. Cancer. PMID 28263368 DOI: 10.1002/Cncr.30615 |
0.357 |
|
| 2017 |
Fagerholm R, Khan S, Schmidt MK, García-Closas M, Heikkilä P, Saarela J, Beesley J, Jamshidi M, Aittomäki K, Liu J, Ali HR, Andrulis IL, Beckmann MW, Behrens S, Blows FM, et al. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. Oncotarget. PMID 28179588 DOI: 10.18632/oncotarget.15110 |
0.396 |
|
| 2017 |
Lilge L, Terry MB, Walter J, Pinnaduwage D, Glendon G, Hanna D, Tammemagi ML, Bradbury A, Buys S, Daly M, John EM, Knight JA, Andrulis IL. Non-invasive optical spectroscopic monitoring of breast development during puberty. Breast Cancer Research : Bcr. 19: 12. PMID 28166807 DOI: 10.1186/S13058-017-0805-X |
0.306 |
|
| 2017 |
Walker LC, Marquart L, Pearson JF, Wiggins GA, O'Mara TA, Parsons MT, Barrowdale D, McGuffog L, Dennis J, Benitez J, Slavin TP, Radice P, Frost D, ... ... Andrulis IL, et al. Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. European Journal of Human Genetics : Ejhg. PMID 28145423 DOI: 10.1038/Ejhg.2016.203 |
0.41 |
|
| 2017 |
Terry M, Dite G, Phillips K, Andrulis I, John E, Daly M, Buys S, Hopper J. Abstract P5-08-05: Prospective family cohort analyses of gene-environment interactions in breast cancer: Body mass index Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P5-08-05 |
0.448 |
|
| 2017 |
Terry M, Phillips K, Liao Y, MacInnis R, Dite G, Daly M, John E, Andrulis I, Buys S, Buchsbaum R, Hopper J. Abstract P2-06-01: Non-genetic risk factors improve accuracy of breast cancer risk assessment for women at high familial risk: Comparison of risk estimation models using the prospective family study cohort (ProF-SC) Cancer Research. 77. DOI: 10.1158/1538-7445.Sabcs16-P2-06-01 |
0.396 |
|
| 2016 |
Liu J, Lončar I, Collée JM, Bolla MK, Dennis J, Michailidou K, Wang Q, Andrulis IL, Barile M, Beckmann MW, Behrens S, Benitez J, Blomqvist C, Boeckx B, Bogdanova NV, et al. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk. Scientific Reports. 6: 36874. PMID 27845421 DOI: 10.1038/Srep36874 |
0.414 |
|
| 2016 |
Hamdi Y, Soucy P, Kuchenbaeker KB, Pastinen T, Droit A, Lemaçon A, Adlard J, Aittomäki K, Andrulis IL, Arason A, Arnold N, Arun BK, Azzollini J, Bane A, Barjhoux L, et al. Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3. Breast Cancer Research and Treatment. PMID 27796716 DOI: 10.1007/S10549-016-4018-2 |
0.471 |
|
| 2016 |
Hamdi Y, Soucy P, Adoue V, Michailidou K, Canisius S, Lemaçon A, Droit A, Andrulis IL, Anton-Culver H, Arndt V, Baynes C, Blomqvist C, Bogdanova NV, Bojesen SE, Bolla MK, et al. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Oncotarget. PMID 27792995 DOI: 10.18632/Oncotarget.12818 |
0.528 |
|
| 2016 |
Muranen TA, Blomqvist C, Dörk T, Jakubowska A, Heikkilä P, Fagerholm R, Greco D, Aittomäki K, Bojesen SE, Shah M, Dunning AM, Rhenius V, Hall P, Czene K, Brand JS, ... ... Andrulis IL, et al. Patient survival and tumor characteristics associated with CHEK2:p.I157T - findings from the Breast Cancer Association Consortium. Breast Cancer Research : Bcr. 18: 98. PMID 27716369 DOI: 10.1186/s13058-016-0758-5 |
0.478 |
|
| 2016 |
Muranen TA, Greco D, Blomqvist C, Aittomäki K, Khan S, Hogervorst F, Verhoef S, Pharoah PD, Dunning AM, Shah M, Luben R, Bojesen SE, Nordestgaard BG, Schoemaker M, Swerdlow A, ... ... Andrulis IL, et al. Genetic modifiers of CHEK2*1100delC-associated breast cancer risk. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27711073 DOI: 10.1038/Gim.2016.147 |
0.406 |
|
| 2016 |
Ghoussaini M, French JD, Michailidou K, Nord S, Beesley J, Canisus S, Hillman KM, Kaufmann S, Sivakumaran H, Moradi Marjaneh M, Lee JS, Dennis J, Bolla MK, Wang Q, Dicks E, ... ... Andrulis IL, et al. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. American Journal of Human Genetics. PMID 27640304 DOI: 10.1016/J.Ajhg.2016.07.017 |
0.38 |
|
| 2016 |
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675 |
0.365 |
|
| 2016 |
Darabi H, Beesley J, Droit A, Kar S, Nord S, Moradi Marjaneh M, Soucy P, Michailidou K, Ghoussaini M, Fues Wahl H, Bolla MK, Wang Q, Dennis J, Alonso MR, Andrulis IL, et al. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). Scientific Reports. 6: 32512. PMID 27600471 DOI: 10.1038/Srep32512 |
0.328 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Andrulis I, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.381 |
|
| 2016 |
Horne HN, Chung CC, Zhang H, Yu K, Prokunina-Olsson L, Michailidou K, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, Broeks A, Muir K, Lophatananon A, ... ... Andrulis IL, et al. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. Plos One. 11: e0160316. PMID 27556229 DOI: 10.1371/Journal.Pone.0160316 |
0.375 |
|
| 2016 |
Guo Y, Warren Andersen S, Shu XO, Michailidou K, Bolla MK, Wang Q, Garcia-Closas M, Milne RL, Schmidt MK, Chang-Claude J, Dunning A, Bojesen SE, Ahsan H, Aittomäki K, Andrulis IL, et al. Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent. Plos Medicine. 13: e1002105. PMID 27551723 DOI: 10.1371/Journal.Pmed.1002105 |
0.31 |
|
| 2016 |
Vigorito E, Kuchenbaecker KB, Beesley J, Adlard J, Agnarsson BA, Andrulis IL, Arun BK, Barjhoux L, Belotti M, Benitez J, Berger A, Bojesen A, Bonanni B, Brewer C, Caldes T, et al. Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers. Plos One. 11: e0158801. PMID 27463617 DOI: 10.1371/Journal.Pone.0158801 |
0.369 |
|
| 2016 |
Zeng C, Guo X, Long J, Kuchenbaecker KB, Droit A, Michailidou K, Ghoussaini M, Kar S, Freeman A, Hopper JL, Milne RL, Bolla MK, Wang Q, Dennis J, Agata S, ... ... Andrulis IL, et al. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus. Breast Cancer Research : Bcr. 18: 64. PMID 27459855 DOI: 10.1186/S13058-016-0718-0 |
0.346 |
|
| 2016 |
Wyszynski A, Hong CC, Lam K, Michailidou K, Lytle C, Yao S, Zhang Y, Bolla MK, Wang Q, Dennis J, Hopper JL, Southey MC, Schmidt MK, Broeks A, Muir K, ... ... Andrulis IL, et al. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics. PMID 27402876 DOI: 10.1093/hmg/ddw223 |
0.413 |
|
| 2016 |
Renault AL, Lesueur F, Coulombe Y, Gobeil S, Soucy P, Hamdi Y, Desjardins S, Le Calvez-Kelm F, Vallée M, Voegele C, Hopper JL, Andrulis IL, Southey MC, John EM, et al. ABRAXAS (FAM175A) and Breast Cancer Susceptibility: No Evidence of Association in the Breast Cancer Family Registry. Plos One. 11: e0156820. PMID 27270457 DOI: 10.1371/Journal.Pone.0156820 |
0.476 |
|
| 2016 |
Schmidt MK, Hogervorst F, van Hien R, Cornelissen S, Broeks A, Adank MA, Meijers H, Waisfisz Q, Hollestelle A, Schutte M, van den Ouweland A, Hooning M, Andrulis IL, Anton-Culver H, Antonenkova NN, et al. Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27269948 DOI: 10.1200/Jco.2016.66.5844 |
0.437 |
|
| 2016 |
Li H, Feng B, Miron A, Chen X, Beesley J, Bimeh E, Barrowdale D, John EM, Daly MB, Andrulis IL, Buys SS, Kraft P, Thorne H, Chenevix-Trench G, et al. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 27171545 DOI: 10.1038/Gim.2016.43 |
0.398 |
|
| 2016 |
Pelttari LM, Khan S, Vuorela M, Kiiski JI, Vilske S, Nevanlinna V, Ranta S, Schleutker J, Winqvist R, Kallioniemi A, Dörk T, Bogdanova NV, Figueroa J, Pharoah PD, Schmidt MK, ... ... Andrulis IL, et al. RAD51B in Familial Breast Cancer. Plos One. 11: e0153788. PMID 27149063 DOI: 10.1371/Journal.Pone.0153788 |
0.437 |
|
| 2016 |
Couch FJ, Kuchenbaecker KB, Michailidou K, Mendoza-Fandino GA, Nord S, Lilyquist J, Olswold C, Hallberg E, Agata S, Ahsan H, Aittomäki K, Ambrosone C, Andrulis IL, Anton-Culver H, Arndt V, et al. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nature Communications. 7: 11375. PMID 27117709 DOI: 10.1038/Ncomms11375 |
0.418 |
|
| 2016 |
Shi J, Zhang Y, Zheng W, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Dennis J, Lush M, Milne RL, Shu XO, Beesley J, Kar S, Andrulis IL, Anton-Culver H, et al. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer. International Journal of Cancer. PMID 27087578 DOI: 10.1002/Ijc.30150 |
0.309 |
|
| 2016 |
Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu XO, Schmidt MK, Milne RL, García-Closas M, Chang-Claude J, Lindstrom S, Bojesen SE, Ahsan H, ... ... Andrulis IL, et al. Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes & Control : Ccc. PMID 27053251 DOI: 10.1007/S10552-016-0741-6 |
0.327 |
|
| 2016 |
Piccolo SR, Hoffman LM, Conner T, Shrestha G, Cohen AL, Marks JR, Neumayer LA, Agarwal CA, Beckerle MC, Andrulis IL, Spira AE, Moos PJ, Buys SS, Johnson WE, Bild AH. Integrative analyses reveal signaling pathways underlying familial breast cancer susceptibility. Molecular Systems Biology. 12: 860. PMID 26969729 DOI: 10.15252/Msb.20156506 |
0.311 |
|
| 2016 |
Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, Beesley J, Healey CS, Kar S, Pooley KA, Lopez-Knowles E, Dicks E, Barrowdale D, Sinnott-Armstrong NA, Sallari RC, Hillman KM, ... ... Andrulis IL, et al. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nature Genetics. PMID 26928228 DOI: 10.1038/Ng.3521 |
0.326 |
|
| 2016 |
Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, Shah M, Bolla MK, Wang Q, Dennis J, Ahmad J, Thompson ER, Damiola F, ... ... Andrulis IL, et al. No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing. Journal of Medical Genetics. PMID 26921362 DOI: 10.1136/Jmedgenet-2015-103529 |
0.418 |
|
| 2016 |
Petridis C, Brook MN, Shah V, Kohut K, Gorman P, Caneppele M, Levi D, Papouli E, Orr N, Cox A, Cross SS, Dos-Santos-Silva I, Peto J, Swerdlow A, Schoemaker MJ, ... ... Andrulis IL, et al. Genetic predisposition to ductal carcinoma in situ of the breast. Breast Cancer Research : Bcr. 18: 22. PMID 26884359 DOI: 10.1186/S13058-016-0675-7 |
0.366 |
|
| 2016 |
Silvestri V, Barrowdale D, Mulligan AM, Neuhausen SL, Fox S, Karlan BY, Mitchell G, James P, Thull DL, Zorn KK, Carter NJ, Nathanson KL, Domchek SM, Rebbeck TR, Ramus SJ, ... ... Andrulis IL, et al. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 18: 15. PMID 26857456 DOI: 10.1186/S13058-016-0671-Y |
0.436 |
|
| 2016 |
John EM, Terry MB, Keegan TH, Bradbury AR, Knight JA, Chung WK, Frost CJ, Lilge L, Patrick-Miller L, Schwartz LA, Whittemore AS, Buys SS, Daly MB, Andrulis IL. The LEGACY Girls Study: Growth and development in the context of breast cancer family history. Epidemiology (Cambridge, Mass.). PMID 26829160 DOI: 10.1097/Ede.0000000000000456 |
0.412 |
|
| 2016 |
Young EL, Feng BJ, Stark AW, Damiola F, Durand G, Forey N, Francy TC, Gammon A, Kohlmann WK, Kaphingst KA, McKay-Chopin S, Nguyen-Dumont T, Oliver J, Paquette AM, Pertesi M, ... ... Andrulis IL, et al. Multigene testing of moderate-risk genes: be mindful of the missense. Journal of Medical Genetics. PMID 26787654 DOI: 10.1136/Jmedgenet-2015-103398 |
0.311 |
|
| 2016 |
Meeks HD, Song H, Michailidou K, Bolla MK, Dennis J, Wang Q, Barrowdale D, Frost D, McGuffog L, Ellis S, Feng B, Buys SS, Hopper JL, Southey MC, ... ... Andrulis IL, et al. BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. Journal of the National Cancer Institute. 108. PMID 26586665 DOI: 10.1093/Jnci/Djv315 |
0.421 |
|
| 2016 |
Lee M, Mulligan A, Bull S, Pinnaduwage D, Andrulis I. Abstract A18: Investigating the differential expressions of miRNAs and programmed-death-ligand-1 related to the T-bet positive tumor-infiltrating lymphocytes in axillary-node-negative breast cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Tme16-A18 |
0.339 |
|
| 2015 |
Lei J, Rudolph A, Moysich KB, Behrens S, Goode EL, Bolla MK, Dennis J, Dunning AM, Easton DF, Wang Q, Benitez J, Hopper JL, Southey MC, Schmidt MK, Broeks A, ... ... Andrulis IL, et al. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium. Human Genetics. PMID 26621531 DOI: 10.1007/S00439-015-1616-8 |
0.461 |
|
| 2015 |
Piccolo SR, Andrulis IL, Cohen AL, Conner T, Moos PJ, Spira AE, Buys SS, Johnson WE, Bild AH. Gene-expression patterns in peripheral blood classify familial breast cancer susceptibility. Bmc Medical Genomics. 8: 72. PMID 26538066 DOI: 10.1186/s12920-015-0145-6 |
0.398 |
|
| 2015 |
Bradbury AR, Patrick-Miller L, Schwartz L, Egleston B, Sands CB, Chung WK, Glendon G, McDonald JA, Moore C, Rauch P, Tuchman L, Andrulis IL, Buys SS, Frost CJ, Keegan TH, et al. Psychosocial Adjustment in School-age Girls With a Family History of Breast Cancer. Pediatrics. PMID 26482668 DOI: 10.1542/Peds.2015-0498 |
0.387 |
|
| 2015 |
Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B, Esko T, Johnson AD, Elks CE, Franceschini N, He C, ... ... Andrulis IL, et al. Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. Nature Genetics. PMID 26414677 DOI: 10.1097/01.Ogx.0000473766.71624.99 |
0.394 |
|
| 2015 |
Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Milne RL, Shu XO, Cai Q, Beesley J, Kar SP, Andrulis IL, Anton-Culver H, Arndt V, et al. Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26354892 DOI: 10.1158/1055-9965.Epi-15-0363 |
0.355 |
|
| 2015 |
Zhang B, Shu XO, Delahanty RJ, Zeng C, Michailidou K, Bolla MK, Wang Q, Dennis J, Wen W, Long J, Li C, Dunning AM, Chang-Claude J, Shah M, Perkins BJ, ... ... Andrulis IL, et al. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. Journal of the National Cancer Institute. 107. PMID 26296642 DOI: 10.1093/Jnci/Djv219 |
0.421 |
|
| 2015 |
Terry MB, Phillips KA, Daly MB, John EM, Andrulis IL, Buys SS, Goldgar DE, Knight JA, Whittemore AS, Chung WK, Apicella C, Hopper JL. Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC). International Journal of Epidemiology. PMID 26174520 DOI: 10.1093/Ije/Dyv118 |
0.386 |
|
| 2015 |
Forse CL, Agarwal S, Pinnaduwage D, Gertler F, Condeelis JS, Lin J, Xue X, Johung K, Mulligan AM, Rohan TE, Bull SB, Andrulis IL. Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer. Bmc Cancer. 15: 483. PMID 26112005 DOI: 10.1186/S12885-015-1468-6 |
0.376 |
|
| 2015 |
Darabi H, McCue K, Beesley J, Michailidou K, Nord S, Kar S, Humphreys K, Thompson D, Ghoussaini M, Bolla MK, Dennis J, Wang Q, Canisius S, Scott CG, Apicella C, ... ... Andrulis IL, et al. Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. American Journal of Human Genetics. 97: 22-34. PMID 26073781 DOI: 10.1016/J.Ajhg.2015.05.002 |
0.354 |
|
| 2015 |
Menes TS, Terry MB, Goldgar D, Andrulis IL, Knight JA, John EM, Liao Y, Southey M, Miron A, Chung W, Buys SS. Second primary breast cancer in BRCA1 and BRCA2 mutation carriers: 10-year cumulative incidence in the Breast Cancer Family Registry. Breast Cancer Research and Treatment. 151: 653-60. PMID 25975955 DOI: 10.1007/S10549-015-3419-Y |
0.466 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.376 |
|
| 2015 |
Blein S, Bardel C, Danjean V, McGuffog L, Healey S, Barrowdale D, Lee A, Dennis J, Kuchenbaecker KB, Soucy P, Terry MB, Chung WK, Goldgar DE, Buys SS, ... ... Andrulis IL, et al. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Research : Bcr. 17: 61. PMID 25925750 DOI: 10.1186/S13058-015-0567-2 |
0.357 |
|
| 2015 |
Pirie A, Guo Q, Kraft P, Canisius S, Eccles DM, Rahman N, Nevanlinna H, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, ... ... Andrulis IL, et al. Common germline polymorphisms associated with breast cancer-specific survival. Breast Cancer Research : Bcr. 17: 58. PMID 25897948 DOI: 10.1186/S13058-015-0570-7 |
0.398 |
|
| 2015 |
Guo Q, Schmidt MK, Kraft P, Canisius S, Chen C, Khan S, Tyrer J, Bolla MK, Wang Q, Dennis J, Michailidou K, Lush M, Kar S, Beesley J, Dunning AM, ... ... Andrulis IL, et al. Identification of novel genetic markers of breast cancer survival. Journal of the National Cancer Institute. 107. PMID 25890600 DOI: 10.1093/Jnci/Djv081 |
0.363 |
|
| 2015 |
Stone J, Thompson DJ, Dos Santos Silva I, Scott C, Tamimi RM, Lindstrom S, Kraft P, Hazra A, Li J, Eriksson L, Czene K, Hall P, Jensen M, Cunningham J, Olson JE, ... ... Andrulis IL, et al. Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures. Cancer Research. 75: 2457-67. PMID 25862352 DOI: 10.1158/0008-5472.Can-14-2012 |
0.363 |
|
| 2015 |
Mavaddat N, Pharoah PD, Michailidou K, Tyrer J, Brook MN, Bolla MK, Wang Q, Dennis J, Dunning AM, Shah M, Luben R, Brown J, Bojesen SE, Nordestgaard BG, Nielsen SF, ... ... Andrulis IL, et al. Prediction of breast cancer risk based on profiling with common genetic variants. Journal of the National Cancer Institute. 107. PMID 25855707 DOI: 10.1093/Jnci/Djv036 |
0.405 |
|
| 2015 |
Lei J, Rudolph A, Moysich KB, Rafiq S, Behrens S, Goode EL, Pharoah PP, Seibold P, Fasching PA, Andrulis IL, Kristensen VN, Couch FJ, Hamann U, Hooning MJ, Nevanlinna H, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy. Breast Cancer Research : Bcr. 17: 18. PMID 25849327 DOI: 10.1186/s13058-015-0522-2 |
0.392 |
|
| 2015 |
Rebbeck TR, Mitra N, Wan F, Sinilnikova OM, Healey S, McGuffog L, Mazoyer S, Chenevix-Trench G, Easton DF, Antoniou AC, Nathanson KL, Laitman Y, Kushnir A, Paluch-Shimon S, ... ... Andrulis I, et al. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. Jama. 313: 1347-61. PMID 25849179 DOI: 10.1001/Jama.2014.5985 |
0.516 |
|
| 2015 |
Blanco I, Kuchenbaecker K, Cuadras D, Wang X, Barrowdale D, de Garibay GR, Librado P, Sánchez-Gracia A, Rozas J, Bonifaci N, McGuffog L, Pankratz VS, Islam A, Mateo F, Berenguer A, ... ... Andrulis IL, et al. Assessing associations between the AURKA-HMMR-TPX2-TUBG1 functional module and breast cancer risk in BRCA1/2 mutation carriers. Plos One. 10: e0120020. PMID 25830658 DOI: 10.1371/Journal.Pone.0120020 |
0.447 |
|
| 2015 |
Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, Maranian MJ, Bolla MK, Wang Q, Shah M, Perkins BJ, Czene K, Eriksson M, Darabi H, Brand JS, ... ... Andrulis IL, et al. Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nature Genetics. 47: 373-80. PMID 25751625 DOI: 10.1038/Ng.3242 |
0.371 |
|
| 2015 |
Kabisch M, Lorenzo Bermejo J, Dünnebier T, Ying S, Michailidou K, Bolla MK, Wang Q, Dennis J, Shah M, Perkins BJ, Czene K, Darabi H, Eriksson M, Bojesen SE, Nordestgaard BG, ... ... Andrulis IL, et al. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. Carcinogenesis. 36: 256-71. PMID 25586992 DOI: 10.1093/Carcin/Bgu326 |
0.407 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Andrulis IL, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.354 |
|
| 2015 |
Glubb DM, Maranian MJ, Michailidou K, Pooley KA, Meyer KB, Kar S, Carlebur S, O'Reilly M, Betts JA, Hillman KM, Kaufmann S, Beesley J, Canisius S, Hopper JL, Southey MC, ... ... Andrulis IL, et al. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. American Journal of Human Genetics. 96: 5-20. PMID 25529635 DOI: 10.1016/J.Ajhg.2014.11.009 |
0.328 |
|
| 2015 |
Candido-dos-Reis FJ, Song H, Goode EL, Cunningham JM, Fridley BL, Larson MC, Alsop K, Dicks E, Harrington P, Ramus SJ, de Fazio A, Mitchell G, Fereday S, Bolton KL, Gourley C, ... ... Andrulis I, et al. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 652-7. PMID 25398451 DOI: 10.1158/1078-0432.Ccr-14-2497 |
0.439 |
|
| 2015 |
Peterlongo P, Chang-Claude J, Moysich KB, Rudolph A, Schmutzler RK, Simard J, Soucy P, Eeles RA, Easton DF, Hamann U, Wilkening S, Chen B, Rookus MA, Schmidt MK, van der Baan FH, ... ... Andrulis IL, et al. Candidate genetic modifiers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 308-16. PMID 25336561 DOI: 10.1158/1055-9965.Epi-14-0532 |
0.435 |
|
| 2015 |
Lin WY, Camp NJ, Ghoussaini M, Beesley J, Michailidou K, Hopper JL, Apicella C, Southey MC, Stone J, Schmidt MK, Broeks A, Van't Veer LJ, Th Rutgers EJ, Muir K, Lophatananon A, ... ... Andrulis IL, et al. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Human Molecular Genetics. 24: 285-98. PMID 25168388 DOI: 10.1093/Hmg/Ddu431 |
0.313 |
|
| 2015 |
Forse CL, Agarwal S, Pinnaduwage D, Gertler F, Condeelis JS, Lin J, Xue X, Johung K, Mulligan AM, Rohan TE, Bull SB, Andrulis IL. Menacalc, a quantitative method of metastasis assessment, as a prognostic marker for axillary node-negative breast cancer Bmc Cancer. 15. DOI: 10.1186/s12885-015-1468-6 |
0.313 |
|
| 2015 |
Bradbury AR, Patrick-Miller L, Egleston B, Schwartz L, Sands CB, Chung W, Glendon G, Tuchman L, Moore C, Rauch P, Andrulis I, Buys S, Frost CJ, John EM, Keegan T, et al. Abstract P6-10-17: Psychosocial adjustment, cancer worry and perceived risk in 6-13 year old girls from breast cancer families Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-10-17 |
0.438 |
|
| 2015 |
Kornhauser N, Terry MB, Vahdat LT, Andrulis I, Buys S, Daly M, John E, Hopper JL, Cigler T. Abstract P3-08-04: Aspirin and breast cancer risk for BRCA1 and BRCA2 mutation carriers Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P3-08-04 |
0.529 |
|
| 2015 |
Bryan MS, Kibirya MG, Andrulis I, Chang-Claude J, Ahsan H, Pierce B. Abstract 2787: Exon sequencing of candidate genes for early onset ER negative breast cancer risk reveals novel gene-level associations Epidemiology. 75: 2787-2787. DOI: 10.1158/1538-7445.Am2015-2787 |
0.48 |
|
| 2015 |
Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, Sulem P, Bulik-Sullivan B, Esko T, Johnson AD, Elks CE, Franceschini N, He C, ... ... Andrulis IL, et al. Large-Scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility, and BRCA1-Mediated DNA Repair Obstetrical and Gynecological Survey. 70: 758-762. DOI: 10.1097/01.ogx.0000473766.71624.99 |
0.315 |
|
| 2014 |
Kuchenbaecker KB, Neuhausen SL, Robson M, Barrowdale D, McGuffog L, Mulligan AM, Andrulis IL, Spurdle AB, Schmidt MK, Schmutzler RK, Engel C, Wappenschmidt B, Nevanlinna H, Thomassen M, Southey M, et al. Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers. Breast Cancer Research : Bcr. 16: 3416. PMID 25919761 DOI: 10.1186/S13058-014-0492-9 |
0.372 |
|
| 2014 |
Spurdle AB, Couch FJ, Parsons MT, McGuffog L, Barrowdale D, Bolla MK, Wang Q, Healey S, Schmutzler R, Wappenschmidt B, Rhiem K, Hahnen E, Engel C, Meindl A, Ditsch N, ... ... Andrulis IL, et al. Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia. Breast Cancer Research : Bcr. 16: 3419. PMID 25857409 DOI: 10.1186/S13058-014-0474-Y |
0.377 |
|
| 2014 |
Ghoussaini M, Edwards SL, Michailidou K, Nord S, Cowper-Sal Lari R, Desai K, Kar S, Hillman KM, Kaufmann S, Glubb DM, Beesley J, Dennis J, Bolla MK, Wang Q, Dicks E, ... ... Andrulis IL, et al. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nature Communications. 4: 4999. PMID 25248036 DOI: 10.1038/Ncomms5999 |
0.319 |
|
| 2014 |
Antoniou AC, Casadei S, Heikkinen T, Barrowdale D, Pylkäs K, Roberts J, Lee A, Subramanian D, De Leeneer K, Fostira F, Tomiak E, Neuhausen SL, Teo ZL, Khan S, Aittomäki K, ... ... Andrulis IL, et al. Breast-cancer risk in families with mutations in PALB2. The New England Journal of Medicine. 371: 497-506. PMID 25099575 DOI: 10.1097/Ogx.0000000000000118 |
0.461 |
|
| 2014 |
Park DJ, Tao K, Le Calvez-Kelm F, Nguyen-Dumont T, Robinot N, Hammet F, Odefrey F, Tsimiklis H, Teo ZL, Thingholm LB, Young EL, Voegele C, Lonie A, Pope BJ, Roane TC, ... ... Andrulis IL, et al. Rare mutations in RINT1 predispose carriers to breast and Lynch syndrome-spectrum cancers. Cancer Discovery. 4: 804-15. PMID 25050558 DOI: 10.1158/2159-8290.Cd-14-0212 |
0.431 |
|
| 2014 |
Wimberly H, Han G, Pinnaduwage D, Murphy LC, Yang XR, Andrulis IL, Sherman M, Figueroa J, Rimm DL. ERβ splice variant expression in four large cohorts of human breast cancer patient tumors. Breast Cancer Research and Treatment. 146: 657-67. PMID 25007965 DOI: 10.1007/s10549-014-3050-3 |
0.425 |
|
| 2014 |
Milne RL, Burwinkel B, Michailidou K, Arias-Perez JI, Zamora MP, Menéndez-Rodríguez P, Hardisson D, Mendiola M, González-Neira A, Pita G, Alonso MR, Dennis J, Wang Q, Bolla MK, Swerdlow A, ... ... Andrulis IL, et al. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium. Human Molecular Genetics. 23: 6096-111. PMID 24943594 DOI: 10.1093/Hmg/Ddu311 |
0.346 |
|
| 2014 |
Li J, Lindström LS, Foo JN, Rafiq S, Schmidt MK, Pharoah PD, Michailidou K, Dennis J, Bolla MK, Wang Q, Van 't Veer LJ, Cornelissen S, Rutgers E, Southey MC, Apicella C, ... ... Andrulis IL, et al. 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy. Nature Communications. 5: 4051. PMID 24937182 DOI: 10.1038/Ncomms5051 |
0.336 |
|
| 2014 |
Purrington KS, Slettedahl S, Bolla MK, Michailidou K, Czene K, Nevanlinna H, Bojesen SE, Andrulis IL, Cox A, Hall P, Carpenter J, Yannoukakos D, Haiman CA, Fasching PA, Mannermaa A, et al. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. Human Molecular Genetics. 23: 6034-46. PMID 24927736 DOI: 10.1093/Hmg/Ddu300 |
0.438 |
|
| 2014 |
Damiola F, Pertesi M, Oliver J, Le Calvez-Kelm F, Voegele C, Young EL, Robinot N, Forey N, Durand G, Vallée MP, Tao K, Roane TC, Williams GJ, Hopper JL, Southey MC, ... Andrulis IL, et al. Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study. Breast Cancer Research : Bcr. 16: R58. PMID 24894818 DOI: 10.1186/bcr3669 |
0.455 |
|
| 2014 |
Johnson N, Dudbridge F, Orr N, Gibson L, Jones ME, Schoemaker MJ, Folkerd EJ, Haynes BP, Hopper JL, Southey MC, Dite GS, Apicella C, Schmidt MK, Broeks A, Van't Veer LJ, ... ... Andrulis IL, et al. Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study. Breast Cancer Research : Bcr. 16: R51. PMID 24887515 DOI: 10.1186/Bcr3662 |
0.352 |
|
| 2014 |
Walker MJ, Mirea L, Glendon G, Ritvo P, Andrulis IL, Knight JA, Chiarelli AM. Does perceived risk predict breast cancer screening use? Findings from a prospective cohort study of female relatives from the Ontario site of the breast cancer family registry. Breast (Edinburgh, Scotland). 23: 482-8. PMID 24821458 DOI: 10.1016/j.breast.2014.04.001 |
0.364 |
|
| 2014 |
Lo WW, Pinnaduwage D, Gokgoz N, Wunder JS, Andrulis IL. Aberrant hedgehog signaling and clinical outcome in osteosarcoma. Sarcoma. 2014: 261804. PMID 24799831 DOI: 10.1155/2014/261804 |
0.603 |
|
| 2014 |
Sawyer E, Roylance R, Petridis C, Brook MN, Nowinski S, Papouli E, Fletcher O, Pinder S, Hanby A, Kohut K, Gorman P, Caneppele M, Peto J, Dos Santos Silva I, Johnson N, ... ... Andrulis IL, et al. Genetic predisposition to in situ and invasive lobular carcinoma of the breast. Plos Genetics. 10: e1004285. PMID 24743323 DOI: 10.1371/Journal.Pgen.1004285 |
0.411 |
|
| 2014 |
Osorio A, Milne RL, Kuchenbaecker K, Vaclová T, Pita G, Alonso R, Peterlongo P, Blanco I, de la Hoya M, Duran M, DÃez O, Ramón Y Cajal T, Konstantopoulou I, MartÃnez-Bouzas C, Andrés Conejero R, ... ... Andrulis I, et al. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers. Plos Genetics. 10: e1004256. PMID 24698998 DOI: 10.1371/Journal.Pgen.1004256 |
0.508 |
|
| 2014 |
Agarwal D, Pineda S, Michailidou K, Herranz J, Pita G, Moreno LT, Alonso MR, Dennis J, Wang Q, Bolla MK, Meyer KB, Menéndez-RodrÃguez P, Hardisson D, Mendiola M, González-Neira A, ... ... Andrulis IL, et al. FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium. British Journal of Cancer. 110: 1088-100. PMID 24548884 DOI: 10.1038/Bjc.2013.769 |
0.415 |
|
| 2014 |
Work ME, John EM, Andrulis IL, Knight JA, Liao Y, Mulligan AM, Southey MC, Giles GG, Dite GS, Apicella C, Hibshoosh H, Hopper JL, Terry MB. Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry. British Journal of Cancer. 110: 1367-77. PMID 24548865 DOI: 10.1038/Bjc.2013.807 |
0.409 |
|
| 2014 |
Ahsan H, Halpern J, Kibriya MG, Pierce BL, Tong L, Gamazon E, McGuire V, Felberg A, Shi J, Jasmine F, Roy S, Brutus R, Argos M, Melkonian S, Chang-Claude J, ... Andrulis I, et al. A genome-wide association study of early-onset breast cancer identifies PFKM as a novel breast cancer gene and supports a common genetic spectrum for breast cancer at any age. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 658-69. PMID 24493630 DOI: 10.1158/1055-9965.Epi-13-0340 |
0.478 |
|
| 2014 |
Schoeps A, Rudolph A, Seibold P, Dunning AM, Milne RL, Bojesen SE, Swerdlow A, Andrulis I, Brenner H, Behrens S, Orr N, Jones M, Ashworth A, Li J, Cramp H, et al. Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genetic Epidemiology. 38: 84-93. PMID 24248812 DOI: 10.1002/gepi.21771 |
0.307 |
|
| 2014 |
Milne RL, Herranz J, Michailidou K, Dennis J, Tyrer JP, Zamora MP, Arias-Perez JI, González-Neira A, Pita G, Alonso MR, Wang Q, Bolla MK, Czene K, Eriksson M, Humphreys K, ... ... Andrulis IL, et al. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Human Molecular Genetics. 23: 1934-46. PMID 24242184 DOI: 10.1093/Hmg/Ddt581 |
0.365 |
|
| 2014 |
Lo WW, Wunder JS, Dickson BC, Campbell V, McGovern K, Alman BA, Andrulis IL. Involvement and targeted intervention of dysregulated Hedgehog signaling in osteosarcoma. Cancer. 120: 537-47. PMID 24151134 DOI: 10.1002/Cncr.28439 |
0.546 |
|
| 2014 |
Walker MJ, Mirea L, Cooper K, Nabavi M, Glendon G, Andrulis IL, Knight JA, O'Malley FP, Chiarelli AM. Impact of familial risk and mammography screening on prognostic indicators of breast disease among women from the Ontario site of the Breast Cancer Family Registry. Familial Cancer. 13: 163-72. PMID 24097051 DOI: 10.1007/s10689-013-9689-9 |
0.387 |
|
| 2014 |
Feeley LP, Mulligan AM, Pinnaduwage D, Bull SB, Andrulis IL. Distinguishing luminal breast cancer subtypes by Ki67, progesterone receptor or TP53 status provides prognostic information. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 27: 554-61. PMID 24051696 DOI: 10.1038/modpathol.2013.153 |
0.329 |
|
| 2013 |
Meyer KB, O'Reilly M, Michailidou K, Carlebur S, Edwards SL, French JD, Prathalingham R, Dennis J, Bolla MK, Wang Q, de Santiago I, Hopper JL, Tsimiklis H, Apicella C, Southey MC, ... ... Andrulis IL, et al. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. American Journal of Human Genetics. 93: 1046-60. PMID 24290378 DOI: 10.1016/J.Ajhg.2013.10.026 |
0.31 |
|
| 2013 |
Walker MJ, Chiarelli AM, Mirea L, Glendon G, Ritvo P, Andrulis IL, Knight JA. Accuracy of Self-Reported Screening Mammography Use: Examining Recall among Female Relatives from the Ontario Site of the Breast Cancer Family Registry. Isrn Oncology. 2013: 810573. PMID 23984098 DOI: 10.1155/2013/810573 |
0.33 |
|
| 2013 |
Phillips KA, Milne RL, Rookus MA, Daly MB, Antoniou AC, Peock S, Frost D, Easton DF, Ellis S, Friedlander ML, Buys SS, Andrieu N, Noguès C, Stoppa-Lyonnet D, Bonadona V, ... ... Andrulis IL, et al. Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3091-9. PMID 23918944 DOI: 10.1200/Jco.2012.47.8313 |
0.474 |
|
| 2013 |
John EM, McGuire V, Thomas D, Haile R, Ozcelik H, Milne RL, Felberg A, West DW, Miron A, Knight JA, Terry MB, Daly M, Buys SS, Andrulis IL, Hopper JL, et al. Diagnostic chest X-rays and breast cancer risk before age 50 years for BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1547-56. PMID 23853209 DOI: 10.1158/1055-9965.Epi-13-0189 |
0.417 |
|
| 2013 |
Bane A, Viloria-Petit A, Pinnaduwage D, Mulligan AM, O'Malley FP, Andrulis IL. Clinical-pathologic significance of cancer stem cell marker expression in familial breast cancers. Breast Cancer Research and Treatment. 140: 195-205. PMID 23813303 DOI: 10.1007/S10549-013-2591-1 |
0.388 |
|
| 2013 |
Teo ZL, Provenzano E, Dite GS, Park DJ, Apicella C, Sawyer SD, James PA, Mitchell G, Trainer AH, Lindeman GJ, Shackleton K, Cicciarelli L, Buys SS, Andrulis IL, et al. Tumour morphology predicts PALB2 germline mutation status. British Journal of Cancer. 109: 154-63. PMID 23787919 DOI: 10.1038/Bjc.2013.295 |
0.391 |
|
| 2013 |
Nickels S, Truong T, Hein R, Stevens K, Buck K, Behrens S, Eilber U, Schmidt M, Häberle L, Vrieling A, Gaudet M, Figueroa J, Schoof N, Spurdle AB, Rudolph A, ... ... Andrulis IL, et al. Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. Plos Genetics. 9: e1003284. PMID 23544014 DOI: 10.1371/Journal.Pgen.1003284 |
0.345 |
|
| 2013 |
Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, Soucy P, Fredericksen Z, Barrowdale D, Dennis J, Gaudet MM, Dicks E, Kosel M, Healey S, Sinilnikova OM, ... ... Andrulis IL, et al. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk. Plos Genetics. 9: e1003212. PMID 23544013 DOI: 10.1371/Journal.Pgen.1003212 |
0.402 |
|
| 2013 |
Gaudet MM, Kuchenbaecker KB, Vijai J, Klein RJ, Kirchhoff T, McGuffog L, Barrowdale D, Dunning AM, Lee A, Dennis J, Healey S, Dicks E, Soucy P, Sinilnikova OM, Pankratz VS, ... ... Andrulis IL, et al. Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. Plos Genetics. 9: e1003173. PMID 23544012 DOI: 10.1371/Journal.Pgen.1003173 |
0.483 |
|
| 2013 |
French JD, Ghoussaini M, Edwards SL, Meyer KB, Michailidou K, Ahmed S, Khan S, Maranian MJ, O'Reilly M, Hillman KM, Betts JA, Carroll T, Bailey PJ, Dicks E, Beesley J, ... ... Andrulis IL, et al. Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. American Journal of Human Genetics. 92: 489-503. PMID 23540573 DOI: 10.1016/J.Ajhg.2013.01.002 |
0.317 |
|
| 2013 |
Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK, Brook MN, Orr N, Rhie SK, Riboli E, Feigelson HS, Le Marchand L, Buring JE, Eccles D, Miron P, Fasching PA, ... ... Andrulis IL, et al. Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nature Genetics. 45: 392-8, 398e1-2. PMID 23535733 DOI: 10.1038/Ng.2561 |
0.395 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Andrulis IL, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.35 |
|
| 2013 |
Michailidou K, Hall P, Gonzalez-Neira A, Ghoussaini M, Dennis J, Milne RL, Schmidt MK, Chang-Claude J, Bojesen SE, Bolla MK, Wang Q, Dicks E, Lee A, Turnbull C, Rahman N, ... ... Andrulis IL, et al. Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nature Genetics. 45: 353-61, 361e1-2. PMID 23535729 DOI: 10.1038/Ng.2563 |
0.401 |
|
| 2013 |
Knight JF, Lesurf R, Zhao H, Pinnaduwage D, Davis RR, Saleh SM, Zuo D, Naujokas MA, Chughtai N, Herschkowitz JI, Prat A, Mulligan AM, Muller WJ, Cardiff RD, Gregg JP, ... Andrulis IL, et al. Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 110: E1301-10. PMID 23509284 DOI: 10.1073/Pnas.1210353110 |
0.426 |
|
| 2013 |
Mocci E, Milne RL, Méndez-Villamil EY, Hopper JL, John EM, Andrulis IL, Chung WK, Daly M, Buys SS, Malats N, Goldgar DE. Risk of pancreatic cancer in breast cancer families from the breast cancer family registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 803-11. PMID 23456555 DOI: 10.1158/1055-9965.EPI-12-0195 |
0.418 |
|
| 2013 |
Rinella ES, Shao Y, Yackowski L, Pramanik S, Oratz R, Schnabel F, Guha S, LeDuc C, Campbell CL, Klugman SD, Terry MB, Senie RT, Andrulis IL, Daly M, John EM, et al. Genetic variants associated with breast cancer risk for Ashkenazi Jewish women with strong family histories but no identifiable BRCA1/2 mutation. Human Genetics. 132: 523-36. PMID 23354978 DOI: 10.1007/S00439-013-1269-4 |
0.408 |
|
| 2013 |
Forse CL, Yilmaz YE, Pinnaduwage D, O'Malley FP, Mulligan AM, Bull SB, Andrulis IL. Elevated expression of podocalyxin is associated with lymphatic invasion, basal-like phenotype, and clinical outcome in axillary lymph node-negative breast cancer. Breast Cancer Research and Treatment. 137: 709-19. PMID 23288345 DOI: 10.1007/s10549-012-2392-y |
0.435 |
|
| 2013 |
Zhang FF, John EM, Knight JA, Kaur M, Daly M, Buys S, Andrulis IL, Stearman B, West D, Terry MB. Total energy intake and breast cancer risk in sisters: the Breast Cancer Family Registry. Breast Cancer Research and Treatment. 137: 541-51. PMID 23225141 DOI: 10.1007/S10549-012-2342-8 |
0.374 |
|
| 2013 |
Mulligan AM, Raitman I, Feeley L, Pinnaduwage D, Nguyen LT, O'Malley FP, Ohashi PS, Andrulis IL. Tumoral lymphocytic infiltration and expression of the chemokine CXCL10 in breast cancers from the Ontario Familial Breast Cancer Registry. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 336-46. PMID 23213058 DOI: 10.1158/1078-0432.CCR-11-3314 |
0.437 |
|
| 2012 |
Barisic A, Glendon G, Weerasooriya N, Andrulis IL, Knight JA. Accuracy of Self-Reported Breast Cancer Information among Women from the Ontario Site of the Breast Cancer Family Registry. Journal of Cancer Epidemiology. 2012: 310804. PMID 23316232 DOI: 10.1155/2012/310804 |
0.349 |
|
| 2012 |
Le Calvez-Kelm F, Oliver J, Damiola F, Forey N, Robinot N, Durand G, Voegele C, Vallée MP, Byrnes G, Registry BC, Hopper JL, Southey MC, Andrulis IL, John EM, Tavtigian SV, et al. RAD51 and breast cancer susceptibility: no evidence for rare variant association in the Breast Cancer Family Registry study. Plos One. 7: e52374. PMID 23300655 DOI: 10.1371/journal.pone.0052374 |
0.482 |
|
| 2012 |
Weischer M, Nordestgaard BG, Pharoah P, Bolla MK, Nevanlinna H, Van't Veer LJ, Garcia-Closas M, Hopper JL, Hall P, Andrulis IL, Devilee P, Fasching PA, Anton-Culver H, Lambrechts D, Hooning M, et al. CHEK2*1100delC heterozygosity in women with breast cancer associated with early death, breast cancer-specific death, and increased risk of a second breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 4308-16. PMID 23109706 DOI: 10.1200/JCO.2012.42.7336 |
0.412 |
|
| 2012 |
Stevens KN, Wang X, Fredericksen Z, Pankratz VS, Greene MH, Andrulis IL, Thomassen M, Caligo M, Nathanson KL, Jakubowska A, Osorio A, Hamann U, Godwin AK, Stoppa-Lyonnet D, et al. Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers. Breast Cancer Research and Treatment. 136: 295-302. PMID 23011509 DOI: 10.1007/S10549-012-2255-6 |
0.465 |
|
| 2012 |
Warren H, Dudbridge F, Fletcher O, Orr N, Johnson N, Hopper JL, Apicella C, Southey MC, Mahmoodi M, Schmidt MK, Broeks A, Cornelissen S, Braaf LM, Muir KR, Lophatananon A, ... ... Andrulis IL, et al. 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1783-91. PMID 22859399 DOI: 10.1158/1055-9965.Epi-12-0526 |
0.401 |
|
| 2012 |
Zhang LR, Chiarelli AM, Glendon G, Mirea L, Knight JA, Andrulis IL, Ritvo P. Worry is good for breast cancer screening: a study of female relatives from the ontario site of the breast cancer family registry. Journal of Cancer Epidemiology. 2012: 545062. PMID 22792104 DOI: 10.1155/2012/545062 |
0.373 |
|
| 2012 |
Ritvo P, Edwards SA, Glendon G, Mirea L, Knight JA, Andrulis IL, Chiarelli AM. Beliefs about optimal age and screening frequency predict breast screening adherence in a prospective study of female relatives from the Ontario site of the Breast Cancer Family Registry. Bmc Public Health. 12: 518. PMID 22788119 DOI: 10.1186/1471-2458-12-518 |
0.32 |
|
| 2012 |
Kirchhoff T, Gaudet MM, Antoniou AC, McGuffog L, Humphreys MK, Dunning AM, Bojesen SE, Nordestgaard BG, Flyger H, Kang D, Yoo KY, Noh DY, Ahn SH, Dork T, Schürmann P, ... ... Andrulis IL, et al. Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. Plos One. 7: e35706. PMID 22768030 DOI: 10.1371/journal.pone.0035706 |
0.436 |
|
| 2012 |
Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen X, Bove B, Hopper JL, John EM, Andrulis I, Daly M, et al. Identification of fifteen novel germline variants in the BRCA1 3'UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Human Mutation. 33: 1665-75. PMID 22753153 DOI: 10.1002/Humu.22159 |
0.372 |
|
| 2012 |
Ding YC, McGuffog L, Healey S, Friedman E, Laitman Y, Paluch-Shimon S, Kaufman B, Liljegren A, Lindblom A, Olsson H, Kristoffersson U, Stenmark-Askmalm M, Melin B, Domchek SM, ... ... Andrulis IL, et al. A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1362-70. PMID 22729394 DOI: 10.1158/1055-9965.Epi-12-0229 |
0.432 |
|
| 2012 |
Jakubowska A, Rozkrut D, Antoniou A, Hamann U, Scott RJ, McGuffog L, Healy S, Sinilnikova OM, Rennert G, Lejbkowicz F, Flugelman A, Andrulis IL, Glendon G, Ozcelik H, et al. Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. British Journal of Cancer. 106: 2016-24. PMID 22669161 DOI: 10.1038/Bjc.2012.160 |
0.448 |
|
| 2012 |
Work ME, Andrulis IL, John EM, Hopper JL, Liao Y, Zhang FF, Knight JA, West DW, Milne RL, Giles GG, Longacre TA, O'Malley F, Mulligan AM, Southey MC, Hibshoosh H, et al. Risk factors for uncommon histologic subtypes of breast cancer using centralized pathology review in the Breast Cancer Family Registry. Breast Cancer Research and Treatment. 134: 1209-20. PMID 22527103 DOI: 10.1007/S10549-012-2056-Y |
0.387 |
|
| 2012 |
Park DJ, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, Neuhausen SL, John EM, Andrulis IL, Terry MB, Daly M, Buys S, Le Calvez-Kelm F, Lonie A, Pope BJ, et al. Rare mutations in XRCC2 increase the risk of breast cancer. American Journal of Human Genetics. 90: 734-9. PMID 22464251 DOI: 10.1016/J.Ajhg.2012.02.027 |
0.465 |
|
| 2012 |
Lambrechts D, Truong T, Justenhoven C, Humphreys MK, Wang J, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Cornelissen S, van Hien R, Sawyer E, Tomlinson I, ... ... Andrulis IL, et al. 11q13 is a susceptibility locus for hormone receptor positive breast cancer. Human Mutation. 33: 1123-32. PMID 22461340 DOI: 10.1002/humu.22089 |
0.341 |
|
| 2012 |
Vachon CM, Scott CG, Fasching PA, Hall P, Tamimi RM, Li J, Stone J, Apicella C, Odefrey F, Gierach GL, Jud SM, Heusinger K, Beckmann MW, Pollan M, Fernández-Navarro P, ... ... Andrulis IL, et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 1156-66. PMID 22454379 DOI: 10.1158/1055-9965.Epi-12-0066 |
0.405 |
|
| 2012 |
Couch FJ, Gaudet MM, Antoniou AC, Ramus SJ, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, Wang X, Kirchhoff T, McGuffog L, Barrowdale D, Lee A, Healey S, Sinilnikova OM, ... Andrulis IL, et al. Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 645-57. PMID 22351618 DOI: 10.1158/1055-9965.Epi-11-0888 |
0.474 |
|
| 2012 |
Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Lee A, Barrowdale D, Healey S, Sinilnikova OM, Caligo MA, Loman N, Harbst K, Lindblom A, Arver B, ... ... Andrulis IL, et al. Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers. Breast Cancer Research : Bcr. 14: R33. PMID 22348646 DOI: 10.1186/Bcr3121 |
0.354 |
|
| 2012 |
Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, Lindblom A, Nevanlinna H, Greco D, Aittomäki K, Blomqvist C, Chang-Claude J, Vrieling A, Flesch-Janys D, Sinn HP, Wang-Gohrke S, ... ... Andrulis IL, et al. 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Research. 72: 1795-803. PMID 22331459 DOI: 10.1158/0008-5472.Can-11-3364 |
0.453 |
|
| 2012 |
Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, BenÃtez J, GarcÃa MJ, ... ... Andrulis IL, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. Jama. 307: 382-90. PMID 22274685 DOI: 10.1001/Jama.2012.20 |
0.365 |
|
| 2012 |
Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, Dicks E, Dennis J, Wang Q, Humphreys MK, Luccarini C, Baynes C, Conroy D, Maranian M, Ahmed S, Driver K, ... ... Andrulis IL, et al. Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nature Genetics. 44: 312-8. PMID 22267197 DOI: 10.1038/Ng.1049 |
0.428 |
|
| 2012 |
Ramus SJ, Antoniou AC, Kuchenbaecker KB, Soucy P, Beesley J, Chen X, McGuffog L, Sinilnikova OM, Healey S, Barrowdale D, Lee A, Thomassen M, Gerdes AM, Kruse TA, Jensen UB, ... ... Andrulis IL, et al. Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers. Human Mutation. 33: 690-702. PMID 22253144 DOI: 10.1002/Humu.22025 |
0.316 |
|
| 2012 |
Goodwin PJ, Phillips KA, West DW, Ennis M, Hopper JL, John EM, O'Malley FP, Milne RL, Andrulis IL, Friedlander ML, Southey MC, Apicella C, Giles GG, Longacre TA. Breast cancer prognosis in BRCA1 and BRCA2 mutation carriers: an International Prospective Breast Cancer Family Registry population-based cohort study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 19-26. PMID 22147742 DOI: 10.1200/JCO.2010.33.0068 |
0.462 |
|
| 2012 |
Mavaddat N, Barrowdale D, Andrulis IL, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Spurdle A, Robson M, Sherman M, Mulligan AM, Couch FJ, Engel C, McGuffog L, Healey S, et al. Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 134-47. PMID 22144499 DOI: 10.1158/1055-9965.Epi-11-0775 |
0.462 |
|
| 2012 |
Southey M, Park D, Lesueur F, Odefrey F, Nguyen-Dumont T, Hammet F, Neuhausen S, John E, Andrulis I, Chenevix-Trench G, Baglietto L, Calvez-Kelm FL, Pertesi M, Lonie A, Pope B, et al. Identification of new breast cancer predisposition genes via whole exome sequencing Hereditary Cancer in Clinical Practice. 10: 1-2. DOI: 10.1186/1897-4287-10-S2-A40 |
0.537 |
|
| 2012 |
Work ME, John EM, Hopper JL, Andrulis IL, Terry MB. Abstract B98: Parity, breastfeeding and oral contraceptive use and risk of estrogen- and progesterone-negative breast cancer in the Breast Cancer Family Registry Cancer Prevention Research. 5: B98-B98. DOI: 10.1158/1940-6207.Prev-12-B98 |
0.418 |
|
| 2012 |
Porat RM, Pasic I, Shlien A, Gokgoz N, Andrulis I, Wunder JS, Malkin D. Abstract 1447: Investigating susceptibility to sporadic osteosarcoma by genome-wide copy number analysis Cancer Research. 72: 1447-1447. DOI: 10.1158/1538-7445.Am2012-1447 |
0.407 |
|
| 2011 |
Greenwood CM, Paterson AD, Linton L, Andrulis IL, Apicella C, Dimitromanolakis A, Kriukov V, Martin LJ, Salleh A, Samiltchuk E, Parekh RV, Southey MC, John EM, Hopper JL, Boyd NF, et al. A genome-wide linkage study of mammographic density, a risk factor for breast cancer. Breast Cancer Research : Bcr. 13: R132. PMID 22188651 DOI: 10.1186/bcr3078 |
0.369 |
|
| 2011 |
Mulligan AM, Couch FJ, Barrowdale D, Domchek SM, Eccles D, Nevanlinna H, Ramus SJ, Robson M, Sherman M, Spurdle AB, Wappenschmidt B, Lee A, McGuffog L, Healey S, Sinilnikova OM, ... ... Andrulis IL, et al. Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Research : Bcr. 13: R110. PMID 22053997 DOI: 10.1186/Bcr3052 |
0.466 |
|
| 2011 |
Kurian AW, Gong GD, John EM, Johnston DA, Felberg A, West DW, Miron A, Andrulis IL, Hopper JL, Knight JA, Ozcelik H, Dite GS, Apicella C, Southey MC, Whittemore AS. Breast cancer risk for noncarriers of family-specific BRCA1 and BRCA2 mutations: findings from the Breast Cancer Family Registry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4505-9. PMID 22042950 DOI: 10.1200/Jco.2010.34.4440 |
0.465 |
|
| 2011 |
Stevens KN, Garcia-Closas M, Fredericksen Z, Kosel M, Pankratz VS, Hopper JL, Dite GS, Apicella C, Southey MC, Schmidt MK, Broeks A, Van 't Veer LJ, Tollenaar RA, Fasching PA, Beckmann MW, ... ... Andrulis I, et al. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. British Journal of Cancer. 105: 1934-9. PMID 22033276 DOI: 10.1038/Bjc.2011.448 |
0.465 |
|
| 2011 |
Cox DG, Simard J, Sinnett D, Hamdi Y, Soucy P, Ouimet M, Barjhoux L, Verny-Pierre C, McGuffog L, Healey S, Szabo C, Greene MH, Mai PL, Andrulis IL, et al. Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. Human Molecular Genetics. 20: 4732-47. PMID 21890493 DOI: 10.1093/Hmg/Ddr388 |
0.458 |
|
| 2011 |
Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL, Southey MC, Apicella C, Hammet F, Schmidt MK, Broeks A, Tollenaar RA, Van't Veer LJ, Fasching PA, Beckmann MW, Ekici AB, ... ... Andrulis I, et al. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Human Molecular Genetics. 20: 4693-706. PMID 21852249 DOI: 10.1093/Hmg/Ddr368 |
0.491 |
|
| 2011 |
Tram E, Ibrahim-Zada I, Briollais L, Knight JA, Andrulis IL, Ozcelik H. Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR). Breast Cancer Research : Bcr. 13: R77. PMID 21835029 DOI: 10.1186/Bcr2926 |
0.376 |
|
| 2011 |
Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, ... ... Andrulis IL, et al. Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Research. 71: 5792-805. PMID 21799032 DOI: 10.1158/0008-5472.Can-11-0773 |
0.444 |
|
| 2011 |
Milne RL, Goode EL, GarcÃa-Closas M, Couch FJ, Severi G, Hein R, Fredericksen Z, Malats N, Zamora MP, Arias Pérez JI, BenÃtez J, Dörk T, Schürmann P, Karstens JH, Hillemanns P, ... ... Andrulis IL, et al. Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 2222-31. PMID 21795498 DOI: 10.1158/1055-9965.EPI-11-0569 |
0.382 |
|
| 2011 |
Goldgar DE, Healey S, Dowty JG, Da Silva L, Chen X, Spurdle AB, Terry MB, Daly MJ, Buys SM, Southey MC, Andrulis I, John EM, Khanna KK, Hopper JL, Oefner PJ, et al. Rare variants in the ATM gene and risk of breast cancer. Breast Cancer Research : Bcr. 13: R73. PMID 21787400 DOI: 10.1186/Bcr2919 |
0.512 |
|
| 2011 |
Campitelli MA, Chiarelli AM, Mirea L, Stewart L, Glendon G, Ritvo P, Andrulis IL, Knight JA. Adherence to breast and ovarian cancer screening recommendations for female relatives from the Ontario site of the Breast Cancer Family Registry. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 20: 492-500. PMID 21691207 DOI: 10.1097/CEJ.0b013e3283476217 |
0.359 |
|
| 2011 |
Im KM, Kirchhoff T, Wang X, Green T, Chow CY, Vijai J, Korn J, Gaudet MM, Fredericksen Z, Shane Pankratz V, Guiducci C, Crenshaw A, McGuffog L, Kartsonaki C, Morrison J, ... ... Andrulis IL, et al. Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Human Genetics. 130: 685-99. PMID 21597964 DOI: 10.1007/S00439-011-1003-Z |
0.301 |
|
| 2011 |
Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, Apicella C, Smith LD, Hammet F, Southey MC, Van 't Veer LJ, de Groot R, Smit VT, Fasching PA, Beckmann MW, ... ... Andrulis IL, et al. Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Human Molecular Genetics. 20: 3289-303. PMID 21596841 DOI: 10.1093/Hmg/Ddr228 |
0.384 |
|
| 2011 |
Antoniou AC, Kartsonaki C, Sinilnikova OM, Soucy P, McGuffog L, Healey S, Lee A, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Cattaneo E, Barile M, Pensotti V, Pasini B, ... ... Andrulis IL, et al. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 20: 3304-21. PMID 21593217 DOI: 10.1093/Hmg/Ddr226 |
0.427 |
|
| 2011 |
Zhang LR, Chiarelli AM, Glendon G, Mirea L, Edwards S, Knight JA, Andrulis IL, Ritvo P. Influence of perceived breast cancer risk on screening behaviors of female relatives from the Ontario site of the Breast Cancer Family Registry. European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (Ecp). 20: 255-62. PMID 21467941 DOI: 10.1097/CEJ.0b013e3283447467 |
0.401 |
|
| 2011 |
Mulligan AM, Pinnaduwage D, Bane AL, Bull SB, O'Malley FP, Andrulis IL. CK8/18 expression, the basal phenotype, and family history in identifying BRCA1-associated breast cancer in the Ontario site of the breast cancer family registry. Cancer. 117: 1350-9. PMID 21425134 DOI: 10.1002/cncr.25642 |
0.439 |
|
| 2011 |
Asimit JL, Andrulis IL, Bull SB. Regression models, scan statistics and reappearance probabilities to detect regions of association between gene expression and copy number. Statistics in Medicine. 30: 1157-78. PMID 21337593 DOI: 10.1002/sim.4193 |
0.325 |
|
| 2011 |
Bane AL, Mulligan AM, Pinnaduwage D, O'Malley FP, Andrulis IL. EMSY and CCND1 amplification in familial breast cancer: From the Ontario site of the Breast Cancer Family Registry Breast Cancer Research and Treatment. 127: 831-839. PMID 21327470 DOI: 10.1007/s10549-011-1380-y |
0.475 |
|
| 2011 |
Smith LD, Tesoriero AA, Wong EM, Ramus SJ, O'Malley FP, Mulligan AM, Terry MB, Senie RT, Santella RM, John EM, Andrulis IL, Ozcelik H, Daly MB, Godwin AK, Buys SS, et al. Contribution of large genomic BRCA1 alterations to early-onset breast cancer selected for family history and tumour morphology: a report from The Breast Cancer Family Registry. Breast Cancer Research : Bcr. 13: R14. PMID 21281505 DOI: 10.1186/Bcr2822 |
0.414 |
|
| 2011 |
Le Calvez-Kelm F, Lesueur F, Damiola F, Vallée M, Voegele C, Babikyan D, Durand G, Forey N, McKay-Chopin S, Robinot N, Nguyen-Dumont T, Thomas A, Byrnes GB, Hopper JL, Southey MC, ... Andrulis IL, et al. Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study. Breast Cancer Research : Bcr. 13: R6. PMID 21244692 DOI: 10.1186/bcr2810 |
0.448 |
|
| 2011 |
Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL, Gaudet M, Schmidt MK, Broeks A, Cox A, Fasching PA, Hein R, Spurdle AB, Blows F, Driver K, ... ... Andrulis IL, et al. Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. Journal of the National Cancer Institute. 103: 250-63. PMID 21191117 DOI: 10.1093/Jnci/Djq526 |
0.363 |
|
| 2011 |
Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, ... ... Andrulis IL, et al. Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. Journal of the National Cancer Institute. 103: 105-16. PMID 21169536 DOI: 10.1093/Jnci/Djq494 |
0.423 |
|
| 2011 |
Wu HC, John EM, Ferris JS, Keegan TH, Chung WK, Andrulis I, Delgado-Cruzata L, Kappil M, Gonzalez K, Santella RM, Terry MB. Global DNA methylation levels in girls with and without a family history of breast cancer. Epigenetics : Official Journal of the Dna Methylation Society. 6: 29-33. PMID 20930546 DOI: 10.4161/Epi.6.1.13393 |
0.411 |
|
| 2011 |
Porat RM, Pasic I, Shlien A, Golgoz N, Andrulis I, Wunder JS, Malkin D. Abstract 5334: Genome-wide copy number analysis reveals two novel loci for susceptibility to sporadic osteosarcoma Cancer Research. 71: 5334-5334. DOI: 10.1158/1538-7445.Am2011-5334 |
0.379 |
|
| 2011 |
Seto A, O'Malley FP, Bull SB, Andrulis I. Abstract 3940: Identifying novel susceptibility genes in genomic aberrant regions in early-onset breast cancer Cancer Research. 71: 3940-3940. DOI: 10.1158/1538-7445.Am2011-3940 |
0.552 |
|
| 2011 |
Work M, John E, Andrulis I, Hopper J, Liao Y, Hibshoosh H, Terry M. Oral Contraceptive Use and Parity Associations with Uncommon Breast Cancer Histologies in the Breast Cancer Family Registry: the Role of Family History Cancer Epidemiology Biomarkers & Prevention. 20: 715-715. DOI: 10.1158/1055-9965.Epi-11-0084 |
0.462 |
|
| 2010 |
Milne RL, Gaudet MM, Spurdle AB, Fasching PA, Couch FJ, BenÃtez J, Arias Pérez JI, Zamora MP, Malats N, Dos Santos Silva I, Gibson LJ, Fletcher O, Johnson N, Anton-Culver H, Ziogas A, ... ... Andrulis IL, et al. Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study. Breast Cancer Research : Bcr. 12: R110. PMID 21194473 DOI: 10.1186/Bcr2797 |
0.422 |
|
| 2010 |
Antoniou AC, Beesley J, McGuffog L, Sinilnikova OM, Healey S, Neuhausen SL, Ding YC, Rebbeck TR, Weitzel JN, Lynch HT, Isaacs C, Ganz PA, Tomlinson G, Olopade OI, Couch FJ, ... ... Andrulis IL, et al. Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Research. 70: 9742-54. PMID 21118973 DOI: 10.1158/0008-5472.Can-10-1907 |
0.42 |
|
| 2010 |
Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, McGuffog L, Kartsonaki C, Morrison J, Healey S, Sinilnikova OM, Stoppa-Lyonnet D, Mazoyer S, ... ... Andrulis IL, et al. Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. Plos Genetics. 6: e1001183. PMID 21060860 DOI: 10.1371/Journal.Pgen.1001183 |
0.39 |
|
| 2010 |
Engel C, Versmold B, Wappenschmidt B, Simard J, Easton DF, Peock S, Cook M, Oliver C, Frost D, Mayes R, Evans DG, Eeles R, Paterson J, Brewer C, ... ... Andrulis IL, et al. Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 2859-68. PMID 20978178 DOI: 10.1158/1055-9965.Epi-10-0517 |
0.455 |
|
| 2010 |
Dite GS, Whittemore AS, Knight JA, John EM, Milne RL, Andrulis IL, Southey MC, McCredie MR, Giles GG, Miron A, Phipps AI, West DW, Hopper JL. Increased cancer risks for relatives of very early-onset breast cancer cases with and without BRCA1 and BRCA2 mutations. British Journal of Cancer. 103: 1103-8. PMID 20877337 DOI: 10.1038/Sj.Bjc.6605876 |
0.44 |
|
| 2010 |
Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R, Sinilnikova OM, Healey S, Morrison J, Kartsonaki C, Lesnick T, Ghoussaini M, Barrowdale D, Peock S, Cook M, ... ... Andrulis IL, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nature Genetics. 42: 885-92. PMID 20852631 DOI: 10.1038/Ng.669 |
0.431 |
|
| 2010 |
Keegan TH, Milne RL, Andrulis IL, Chang ET, Sangaramoorthy M, Phillips KA, Giles GG, Goodwin PJ, Apicella C, Hopper JL, Whittemore AS, John EM. Past recreational physical activity, body size, and all-cause mortality following breast cancer diagnosis: results from the Breast Cancer Family Registry. Breast Cancer Research and Treatment. 123: 531-42. PMID 20140702 DOI: 10.1007/S10549-010-0774-6 |
0.332 |
|
| 2010 |
Glendon G, Frost CJ, Andrulis IL, Hanna D, John EM, Phipps AI, Thompson A, Venne V, Ritvo P. A qualitative study evaluating parental attitudes towards the creation of a female youth cohort (LEGACY) in the Breast Cancer Family Registry. Psycho-Oncology. 19: 93-101. PMID 19415783 DOI: 10.1002/Pon.1543 |
0.33 |
|
| 2010 |
Zhang FF, John EM, West DW, Knight J, Andrulis I, Buys S, Daly M, Stearman B, Kaur M, Vishwanatha J, Morabia A, Terry MB. Abstract 2830: Energy balance and breast cancer risk among sisters pairs in the Breast Cancer Family Registry Study Cancer Research. 70: 2830-2830. DOI: 10.1158/1538-7445.Am10-2830 |
0.459 |
|
| 2010 |
Bordeleau L, Richter S, O'Malley F, Pinnaduwage D, Collins L, Mulligan A, Youngson B, Glendon G, Leong W, Lipa J, McCready D, Andrulis I. Abstract P2-11-01: Molecular Profiling Identifies Differentially Expressed Genes between Normal Breast Tissue from BRCA Carriers and Women at Population Risk Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P2-11-01 |
0.449 |
|
| 2010 |
Le Calvez F, Lesueur F, Damiola F, Voegele C, Durocher F, Hopper J, Southey M, Andrulis I, John E, Tavtigian S. 71 Rare, evolutionary unlikely missense substitutions in CHEK2 confer increased risk of breast cancer European Journal of Cancer Supplements. 8: 19. DOI: 10.1016/S1359-6349(10)70880-6 |
0.415 |
|
| 2009 |
Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F, Lesueur F, Byrnes GB, Chuang SC, Forey N, Feuchtinger C, Gioia L, Hall J, Hashibe M, Herte B, ... ... Andrulis IL, et al. Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. American Journal of Human Genetics. 85: 427-46. PMID 19781682 DOI: 10.1016/J.Ajhg.2009.08.018 |
0.447 |
|
| 2009 |
Yazici H, Terry MB, Cho YH, Senie RT, Liao Y, Andrulis I, Santella RM. Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2723-5. PMID 19755643 DOI: 10.1158/1055-9965.Epi-08-1237 |
0.442 |
|
| 2009 |
Sinilnikova OM, Antoniou AC, Simard J, Healey S, Léoné M, Sinnett D, Spurdle AB, Beesley J, Chen X, Greene MH, Loud JT, Lejbkowicz F, Rennert G, Dishon S, ... Andrulis IL, et al. The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. British Journal of Cancer. 101: 1456-60. PMID 19707196 DOI: 10.1038/Sj.Bjc.6605279 |
0.389 |
|
| 2009 |
Viloria-Petit AM, David L, Jia JY, Erdemir T, Bane AL, Pinnaduwage D, Roncari L, Narimatsu M, Bose R, Moffat J, Wong JW, Kerbel RS, O'Malley FP, Andrulis IL, Wrana JL. A role for the TGFbeta-Par6 polarity pathway in breast cancer progression. Proceedings of the National Academy of Sciences of the United States of America. 106: 14028-33. PMID 19667198 DOI: 10.1073/Pnas.0906796106 |
0.407 |
|
| 2009 |
Antoniou AC, Sinilnikova OM, McGuffog L, Healey S, Nevanlinna H, Heikkinen T, Simard J, Spurdle AB, Beesley J, Chen X, Neuhausen SL, Ding YC, Couch FJ, Wang X, ... ... Andrulis IL, et al. Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. Human Molecular Genetics. 18: 4442-56. PMID 19656774 DOI: 10.1093/Hmg/Ddp372 |
0.43 |
|
| 2009 |
Ponzo MG, Lesurf R, Petkiewicz S, O'Malley FP, Pinnaduwage D, Andrulis IL, Bull SB, Chughtai N, Zuo D, Souleimanova M, Germain D, Omeroglu A, Cardiff RD, Hallett M, Park M. Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancer. Proceedings of the National Academy of Sciences of the United States of America. 106: 12903-8. PMID 19617568 DOI: 10.1073/Pnas.0810402106 |
0.434 |
|
| 2009 |
Phillips KA, Milne RL, West DW, Goodwin PJ, Giles GG, Chang ET, Figueiredo JC, Friedlander ML, Keegan TH, Glendon G, Apicella C, O'Malley FP, Southey MC, Andrulis IL, John EM, et al. Prediagnosis reproductive factors and all-cause mortality for women with breast cancer in the breast cancer family registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1792-7. PMID 19505912 DOI: 10.1158/1055-9965.EPI-08-1014 |
0.39 |
|
| 2009 |
O'Malley FP, Chia S, Tu D, Shepherd LE, Levine MN, Bramwell VH, Andrulis IL, Pritchard KI. Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy. Journal of the National Cancer Institute. 101: 644-50. PMID 19401546 DOI: 10.1093/jnci/djp067 |
0.325 |
|
| 2009 |
Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, Eccles D, Evans DG, Fletcher O, Johnson N, dos Santos Silva I, ... ... Andrulis IL, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nature Genetics. 41: 585-90. PMID 19330027 DOI: 10.1038/Ng.354 |
0.341 |
|
| 2009 |
Fehringer G, Boyd NF, Knight JA, Paterson AD, Dite GS, Giles GG, Southey MC, Andrulis IL, Hopper JL, Ozcelik H. Family-based genetic association study of insulin-like growth factor I microsatellite markers and premenopausal breast cancer risk. Breast Cancer Research and Treatment. 118: 415-24. PMID 19229608 DOI: 10.1007/S10549-009-0336-Y |
0.346 |
|
| 2009 |
Chang ET, Milne RL, Phillips KA, Figueiredo JC, Sangaramoorthy M, Keegan TH, Andrulis IL, Hopper JL, Goodwin PJ, O'Malley FP, Weerasooriya N, Apicella C, Southey MC, Friedlander ML, Giles GG, et al. Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry. Breast Cancer Research and Treatment. 117: 167-76. PMID 19034644 DOI: 10.1007/S10549-008-0255-3 |
0.438 |
|
| 2009 |
Neuhausen SL, Ozcelik H, Southey MC, John EM, Godwin AK, Chung W, Iriondo-Perez J, Miron A, Santella RM, Whittemore A, Andrulis IL, Buys SS, Daly MB, Hopper JL, Seminara D, et al. BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. Breast Cancer Research and Treatment. 116: 379-86. PMID 18704680 DOI: 10.1007/S10549-008-0153-8 |
0.387 |
|
| 2009 |
Bane AL, Pinnaduwage D, Colby S, Reedijk M, Egan SE, Bull SB, O'Malley FP, Andrulis IL. Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors. Breast Cancer Research and Treatment. 117: 183-91. PMID 18563556 DOI: 10.1007/s10549-008-0087-1 |
0.468 |
|
| 2009 |
Rebbeck TR, Antoniou AC, Llopis TC, Nevanlinna H, Aittomäki K, Simard J, Spurdle AB, Couch FJ, Pereira LH, Greene MH, Andrulis IL, Pasche B, Kaklamani V, et al. No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study. Breast Cancer Research and Treatment. 115: 185-92. PMID 18523885 DOI: 10.1007/S10549-008-0064-8 |
0.401 |
|
| 2009 |
Kibriya MG, Jasmine F, Argos M, Andrulis IL, John EM, Chang-Claude J, Ahsan H. A pilot genome-wide association study of early-onset breast cancer. Breast Cancer Research and Treatment. 114: 463-77. PMID 18463975 DOI: 10.1007/S10549-008-0039-9 |
0.354 |
|
| 2009 |
Goodwin P, Phillips K, West D, Ennis M, Hopper J, John E, O'Malley F, Milne R, Andrulis I, Friedlander M, Longacre T. Prognosis in BRCA1, BRCA2 associated breast cancer (BC): a prospective Breast Cancer Family Registry (BCFR) international population-based cohort study. Cancer Research. 69: 2072. DOI: 10.1158/0008-5472.Sabcs-2072 |
0.531 |
|
| 2009 |
Bild A, Sun Y, Soldi R, Conner T, Walker D, Werner T, Spira A, Andrulis I, Buys S, Johnson E. A Genomic Biomarker for Breast Cancer Development in High-Risk Women. Cancer Research. 69: 4059-4059. DOI: 10.1158/0008-5472.Sabcs-09-4059 |
0.524 |
|
| 2009 |
Bane AL, Pinnaduwage D, Colby S, Reedijk M, Egan SE, Bull SB, O’Malley FP, Andrulis IL. Erratum to: Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors Breast Cancer Research and Treatment. 126: 269-269. DOI: 10.1007/s10549-009-0563-2 |
0.415 |
|
| 2008 |
Mulligan AM, Pinnaduwage D, Bull SB, O'Malley FP, Andrulis IL. Prognostic effect of basal-like breast cancers is time dependent: evidence from tissue microarray studies on a lymph node-negative cohort. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4168-74. PMID 18593996 DOI: 10.1158/1078-0432.CCR-07-4543 |
0.313 |
|
| 2008 |
Huggins CJ, Andrulis IL. Cell cycle regulated phosphorylation of LIMD1 in cell lines and expression in human breast cancers. Cancer Letters. 267: 55-66. PMID 18439753 DOI: 10.1016/j.canlet.2008.03.015 |
0.386 |
|
| 2008 |
Antoniou AC, Spurdle AB, Sinilnikova OM, Healey S, Pooley KA, Schmutzler RK, Versmold B, Engel C, Meindl A, Arnold N, Hofmann W, Sutter C, Niederacher D, Deissler H, Caldes T, ... ... Andrulis IL, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. American Journal of Human Genetics. 82: 937-48. PMID 18355772 DOI: 10.1016/J.Ajhg.2008.02.008 |
0.451 |
|
| 2008 |
Onay UV, Aaltonen K, Briollais L, Knight JA, Pabalan N, Kilpivaara O, Andrulis IL, Blomqvist C, Nevanlinna H, Ozcelik H. Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk. Bmc Cancer. 8: 6. PMID 18194538 DOI: 10.1186/1471-2407-8-6 |
0.353 |
|
| 2008 |
O'Malley FP, Thomson T, Julian J, Have C, Cosby R, Crosby R, Gelmon K, Andrulis I, Whelan T. HER2 testing in a population-based study of patients with metastatic breast cancer treated with trastuzumab. Archives of Pathology & Laboratory Medicine. 132: 61-5. PMID 18181675 DOI: 10.1043/1543-2165(2008)132[61:Htiaps]2.0.Co;2 |
0.474 |
|
| 2008 |
Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O'Malley FP, Egan SE, Andrulis IL. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Research and Treatment. 111: 439-48. PMID 17990101 DOI: 10.1007/s10549-007-9805-3 |
0.418 |
|
| 2008 |
Whittemore AS, John EM, Felberg A, McGuire V, West DW, Miron A, Thomas DC, Haile R, Daly M, Godwin A, Ross E, Beck J, Terry MB, Buys SS, Venne V, ... ... Andrulis I, et al. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years Breast Cancer Research and Treatment. 109: 67-75. PMID 17972172 DOI: 10.1007/S10549-007-9621-9 |
0.471 |
|
| 2008 |
Schrader K, Masciari S, Boyd N, Senz J, Kaurah P, Terry MB, John E, Andrulis IL, Knight J, O'Malley FP, Daly M, Bender P, Southey MC, Hopper JL, Garber J, et al. THE ASSOCIATION OF LOBULAR BREAST CANCER WITH GERMLINE MUTATIONS OF CDH1 Clinical & Investigative Medicine. 31: 22. DOI: 10.25011/Cim.V31I4.4826 |
0.446 |
|
| 2007 |
Mastracci TL, Boulos FI, Andrulis ILIL, Lam WL. Genomics and premalignant breast lesions: Clues to the development and progression of lobular breast cancer Breast Cancer Research. 9. PMID 18036272 DOI: 10.1186/bcr1785 |
0.343 |
|
| 2007 |
Antoniou AC, Sinilnikova OM, Simard J, Léoné M, Dumont M, Neuhausen SL, Struewing JP, Stoppa-Lyonnet D, Barjhoux L, Hughes DJ, Coupier I, Belotti M, Lasset C, Bonadona V, Bignon YJ, ... ... Andrulis IL, et al. RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. American Journal of Human Genetics. 81: 1186-200. PMID 17999359 DOI: 10.1086/522611 |
0.403 |
|
| 2007 |
Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. Expression of the circadian clock genes Per1 and Per2 in sporadic and familial breast tumors. Neoplasia (New York, N.Y.). 9: 797-800. PMID 17971899 |
0.429 |
|
| 2007 |
Huggins CJ, Gill M, Andrulis IL. Identification of rare variants in the hLIMD1 gene in breast cancer. Cancer Genetics and Cytogenetics. 178: 36-41. PMID 17889706 DOI: 10.1016/J.CANCERGENCYTO.2007.06.007 |
0.444 |
|
| 2007 |
Apicella C, Dowty JG, Dite GS, Jenkins MA, Senie RT, Daly MB, Andrulis IL, John EM, Buys SS, Li FP, Glendon G, Chung W, Ozcelik H, Miron A, Kotar K, et al. Validation study of the LAMBDA model for predicting the BRCA1 or BRCA2 mutation carrier status of North American Ashkenazi Jewish women. Clinical Genetics. 72: 87-97. PMID 17661812 DOI: 10.1111/J.1399-0004.2007.00841.X |
0.341 |
|
| 2007 |
Couch FJ, Sinilnikova O, Vierkant RA, Pankratz VS, Fredericksen ZS, Stoppa-Lyonnet D, Coupier I, Hughes D, Hardouin A, Berthet P, Peock S, Cook M, Baynes C, Hodgson S, Morrison PJ, ... ... Andrulis IL, et al. AURKA F31I polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a consortium of investigators of modifiers of BRCA1/2 study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1416-21. PMID 17627006 DOI: 10.1158/1055-9965.EPI-07-0129 |
0.474 |
|
| 2007 |
Figueiredo JC, Knight JA, Cho S, Savas S, Onay UV, Briollais L, Goodwin PJ, McLaughlin JR, Andrulis IL, Ozcelik H. Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis. Bmc Cancer. 7: 99. PMID 17567920 DOI: 10.1186/1471-2407-7-99 |
0.421 |
|
| 2007 |
Winter SL, Bosnoyan-Collins L, Pinnaduwage D, Andrulis IL. The interaction of PP1 with BRCA1 and analysis of their expression in breast tumors. Bmc Cancer. 7: 85. PMID 17511879 DOI: 10.1186/1471-2407-7-85 |
0.43 |
|
| 2007 |
John EM, Phipps AI, Knight JA, Milne RL, Dite GS, Hopper JL, Andrulis IL, Southey M, Giles GG, West DW, Whittemore AS. Medical radiation exposure and breast cancer risk: findings from the Breast Cancer Family Registry. International Journal of Cancer. 121: 386-94. PMID 17372900 DOI: 10.1002/Ijc.22668 |
0.384 |
|
| 2007 |
Ozcelik H, Pinnaduwage D, Bull SB, Andrulis IL. Type of TP53 mutation and ERBB2 amplification affects survival in node-negative breast cancer. Breast Cancer Research and Treatment. 105: 255-65. PMID 17221157 DOI: 10.1007/s10549-006-9452-0 |
0.443 |
|
| 2007 |
Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB, Giles G, Godwin AK, Hibshoosh H, Hopper JL, John EM, Layfield L, Longacre T, Miron A, Senie R, ... ... Andrulis IL, et al. BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays American Journal of Surgical Pathology. 31: 121-128. PMID 17197928 DOI: 10.1097/01.Pas.0000213351.49767.0F |
0.471 |
|
| 2006 |
Jarjanazi H, Li H, Andrulis IL, Ozcelik H. Genome wide screening of CAG trinucleotide repeat lengths in breast cancer. Disease Markers. 22: 343-9. PMID 17264405 DOI: 10.1155/2006/951857 |
0.365 |
|
| 2006 |
Figueiredo JC, Ennis M, Knight JA, McLaughlin JR, Hood N, O'Malley F, Andrulis IL, Goodwin PJ. Influence of young age at diagnosis and family history of breast or ovarian cancer on breast cancer outcomes in a population-based cohort study. Breast Cancer Research and Treatment. 105: 69-80. PMID 17115108 DOI: 10.1007/s10549-006-9433-3 |
0.421 |
|
| 2006 |
Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, et al. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1863-70. PMID 17021353 DOI: 10.1158/1055-9965.Epi-06-0258 |
0.418 |
|
| 2006 |
Bernstein JL, Teraoka S, Southey MC, Jenkins MA, Andrulis IL, Knight JA, John EM, Lapinski R, Wolitzer AL, Whittemore AS, West D, Seminara D, Olson ER, Spurdle AB, Chenevix-Trench G, et al. Population-based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Registry. Human Mutation. 27: 1122-8. PMID 16958054 DOI: 10.1002/Humu.20415 |
0.335 |
|
| 2006 |
McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, et al. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages <50 years. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 1565-7. PMID 16896052 DOI: 10.1158/1055-9965.Epi-06-0323 |
0.354 |
|
| 2006 |
Nottage MK, Kopciuk KA, Tzontcheva A, Andrulis IL, Bull SB, Blackstein ME. Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study. Breast Cancer Research : Bcr. 8: R44. PMID 16859523 DOI: 10.1186/bcr1531 |
0.306 |
|
| 2006 |
Pritchard KI, Shepherd LE, O'Malley FP, Andrulis IL, Tu D, Bramwell VH, Levine MN. HER2 and responsiveness of breast cancer to adjuvant chemotherapy. The New England Journal of Medicine. 354: 2103-11. PMID 16707747 DOI: 10.1056/NEJMoa054504 |
0.372 |
|
| 2006 |
Onay VU, Briollais L, Knight JA, Shi E, Wang Y, Wells S, Li H, Rajendram I, Andrulis IL, Ozcelik H. SNP-SNP interactions in breast cancer susceptibility. Bmc Cancer. 6: 114. PMID 16672066 DOI: 10.1186/1471-2407-6-114 |
0.384 |
|
| 2006 |
Smith P, McGuffog L, Easton DF, Mann GJ, Pupo GM, Newman B, Chenevix-Trench G, Szabo C, Southey M, Renard H, Odefrey F, Lynch H, Stoppa-Lyonnet D, Couch F, ... ... Andrulis I, et al. A genome wide linkage search for breast cancer susceptibility genes. Genes, Chromosomes & Cancer. 45: 646-55. PMID 16575876 DOI: 10.1002/Gcc.20330 |
0.453 |
|
| 2006 |
Bernstein JL, Teraoka SN, John EM, Andrulis IL, Knight JA, Lapinski R, Olson ER, Wolitzer AL, Seminara D, Whittemore AS, Concannon P. The CHEK2*1100delC allelic variant and risk of breast cancer: Screening results from the breast cancer family registry Cancer Epidemiology Biomarkers and Prevention. 15: 348-352. PMID 16492927 DOI: 10.1158/1055-9965.Epi-05-0557 |
0.398 |
|
| 2006 |
To MD, Gokgoz N, Doyle TG, Donoviel DB, Knight JA, Hyslop PS, Bernstein A, Andrulis IL. Functional characterization of novel presenilin-2 variants identified in human breast cancers. Oncogene. 25: 3557-64. PMID 16474849 DOI: 10.1038/Sj.Onc.1209397 |
0.416 |
|
| 2006 |
Spurdle AB, Antoniou AC, Kelemen L, Holland H, Peock S, Cook MR, Smith PL, Greene MH, Simard J, Plourde M, Southey MC, Godwin AK, Beck J, Miron A, Daly MB, ... ... Andrulis IL, et al. The AIB1 polyglutamine repeat does not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 76-9. PMID 16434590 DOI: 10.1158/1055-9965.Epi-05-0709 |
0.487 |
|
| 2005 |
Knight JA, John EM, Milne RL, Dite GS, Balbuena R, Shi EJ, Giles GG, Ziogas A, Andrulis IL, Whittemore AS, Hopper JL. An inverse association between ovarian cysts and breast cancer in the breast cancer family registry. International Journal of Cancer. 118: 197-202. PMID 16032703 DOI: 10.1002/Ijc.21298 |
0.406 |
|
| 2005 |
Milne RL, Knight JA, John EM, Dite GS, Balbuena R, Ziogas A, Andrulis IL, West DW, Li FP, Southey MC, Giles GG, McCredie MR, Hopper JL, Whittemore AS. Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 350-6. PMID 15734957 DOI: 10.1158/1055-9965.Epi-04-0376 |
0.421 |
|
| 2005 |
To MD, Faseruk SA, Gokgoz N, Pinnaduwage D, Done SJ, Andrulis IL. LAF-4 is aberrantly expressed in human breast cancer. International Journal of Cancer. Journal International Du Cancer. 115: 568-74. PMID 15704140 DOI: 10.1002/ijc.20881 |
0.649 |
|
| 2005 |
Trudeau ME, Pritchard KI, Chapman JA, Hanna WM, Kahn HJ, Murray D, Sawka CA, Mobbs BG, Andrulis I, McCready DR, Lickley HL. Prognostic factors affecting the natural history of node-negative breast cancer. Breast Cancer Research and Treatment. 89: 35-45. PMID 15666195 DOI: 10.1007/S10549-004-1368-Y |
0.435 |
|
| 2005 |
Bane AL, Tjan S, Parkes RK, Andrulis I, O'Malley FP. Invasive lobular carcinoma: to grade or not to grade. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 18: 621-8. PMID 15605082 DOI: 10.1038/Modpathol.3800273 |
0.367 |
|
| 2004 |
Whittemore AS, Balise RR, Pharoah PD, Dicioccio RA, Oakley-Girvan I, Ramus SJ, Daly M, Usinowicz MB, Garlinghouse-Jones K, Ponder BA, Buys S, Senie R, Andrulis I, John E, Hopper JL, et al. Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations. British Journal of Cancer. 91: 1911-5. PMID 15545966 DOI: 10.1038/Sj.Bjc.6602239 |
0.441 |
|
| 2004 |
Chen W, Cooper TK, Zahnow CA, Overholtzer M, Zhao Z, Ladanyi M, Karp JE, Gokgoz N, Wunder JS, Andrulis IL, Levine AJ, Mankowski JL, Baylin SB. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis. Cancer Cell. 6: 387-98. PMID 15488761 DOI: 10.1016/J.Ccr.2004.08.030 |
0.364 |
|
| 2004 |
John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, et al. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer Breast Cancer Research : Bcr. 6: R375-389. PMID 15217505 DOI: 10.1186/Bcr801 |
0.377 |
|
| 2004 |
Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 583-91. PMID 15066923 |
0.383 |
|
| 2004 |
Mueller RE, Parkes RK, Andrulis I, O'Malley FP. Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples. Genes, Chromosomes & Cancer. 39: 288-97. PMID 14978790 DOI: 10.1002/Gcc.20008 |
0.453 |
|
| 2004 |
Knight JA, Onay UV, Wells S, Li H, Shi EJ, Andrulis IL, Ozcelik H. Genetic variants of GPX1 and SOD2 and breast cancer risk at the Ontario site of the Breast Cancer Family Registry. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 146-9. PMID 14744747 DOI: 10.1158/1055-9965.Epi-03-0164 |
0.446 |
|
| 2004 |
Bull SB, Ozcelik H, Pinnaduwage D, Blackstein ME, Sutherland DA, Pritchard KI, Tzontcheva AT, Sidlofsky S, Hanna WM, Qizilbash AH, Tweeddale ME, Fine S, McCready DR, Andrulis IL. The combination of p53 mutation and neu/erbB-2 amplification is associated with poor survival in node-negative breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 86-96. PMID 14701769 DOI: 10.1200/Jco.2004.09.128 |
0.439 |
|
| 2004 |
Mancuso C, Glendon G, Anson-Cartwright L, Shi EJ, Andrulis I, Knight J. Ethnicity, but not cancer family history, is related to response to a population-based mailed questionnaire. Annals of Epidemiology. 14: 36-43. PMID 14664778 DOI: 10.1016/S1047-2797(03)00073-5 |
0.385 |
|
| 2003 |
Wong JC, Gokgoz N, Alon N, Andrulis IL, Buchwald M. Cloning and mutation analysis of ZFP276 as a candidate tumor suppressor in breast cancer. Journal of Human Genetics. 48: 668-71. PMID 14605947 DOI: 10.1007/S10038-003-0088-1 |
0.384 |
|
| 2003 |
Ozcelik H, Knight JA, Glendon G, Yazici H, Carson N, Ainsworth PJ, Taylor SA, Feilotter H, Carter RF, Boyd NF, Andrulis IL. Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies. Journal of Medical Genetics. 40: e91. PMID 12920083 DOI: 10.1136/jmg.40.8.e91 |
0.374 |
|
| 2002 |
Quenneville LA, Phillips KA, Ozcelik H, Parkes RK, Knight JA, Goodwin PJ, Andrulis IL, O'Malley FP. HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry. Cancer. 95: 2068-75. PMID 12412159 DOI: 10.1002/Cncr.10949 |
0.437 |
|
| 2002 |
Yazici H, Glendon G, Yazici H, Burnie SJ, Saip P, Buyru F, Bengisu E, Andrulis IL, Dalay N, Ozcelik H. BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases. Human Mutation. 20: 28-34. PMID 12112655 DOI: 10.1002/Humu.10090 |
0.345 |
|
| 2002 |
Thompson D, Szabo CI, Mangion J, Oldenburg RA, Odefrey F, Seal S, Barfoot R, Kroeze-Jansema K, Teare D, Rahman N, Renard H, Mann G, Hopper JL, Buys SS, Andrulis IL, et al. Evaluation of linkage of breast cancer to the putative BRCA3 locus on chromosome 13q21 in 128 multiple case families from the Breast Cancer Linkage Consortium. Proceedings of the National Academy of Sciences of the United States of America. 99: 827-31. PMID 11792833 DOI: 10.1073/Pnas.012584499 |
0.396 |
|
| 2002 |
Knight JA, Sutherland HJ, Glendon G, Boyd NF, Andrulis IL. Characteristics associated with participation at various stages at the Ontario site of the cooperative family registry for breast cancer studies. Annals of Epidemiology. 12: 27-33. PMID 11750237 DOI: 10.1016/S1047-2797(01)00253-8 |
0.395 |
|
| 2001 |
Done SJ, Eskandarian S, Bull S, Redston M, Andrulis IL. p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast. Journal of the National Cancer Institute. 93: 700-4. PMID 11333292 DOI: 10.1093/Jnci/93.9.700 |
0.684 |
|
| 2001 |
O’Malley FP, Parkes R, Latta E, Tjan S, Zadro T, Mueller R, Arneson N, Blackstein M, Andrulis I. Comparison of HER2/neu status assessed by quantitative polymerase chain reaction and immunohistochemistry. American Journal of Clinical Pathology. 115: 504-511. PMID 11293897 DOI: 10.1309/Vp4W-5C55-7M09-6Tx3 |
0.386 |
|
| 2001 |
Done SJ, Arneson CR, Ozçelik H, Redston M, Andrulis IL. P53 protein accumulation in non-invasive lesions surrounding p53 mutation positive invasive breast cancers. Breast Cancer Research and Treatment. 65: 111-8. PMID 11261826 |
0.635 |
|
| 2001 |
Sutherland HJ, Lacroix J, Knight J, Andrulis IL, Boyd NF. The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario. Journal of Clinical Epidemiology. 54: 93-8. PMID 11165472 DOI: 10.1016/S0895-4356(00)00263-8 |
0.346 |
|
| 2001 |
Gokgoz N, Sun X, Bull S, Woodgett J, Andrulis I. Analysis of gene expression patterns in breast cancer by microarray technology Nature Genetics. 27: 56-56. DOI: 10.1038/87096 |
0.485 |
|
| 2000 |
Rice JC, Ozcelik H, Maxeiner P, Andrulis I, Futscher BW. Methylation of the BRCA1 promoter is associated with decreased BRCA1 mRNA levels in clinical breast cancer specimens Carcinogenesis. 21: 1761-1765. PMID 10964110 DOI: 10.1093/Carcin/21.9.1761 |
0.527 |
|
| 2000 |
McCready DR, Chapman JA, Hanna WM, Kahn HJ, Murray D, Fish EB, Trudeau ME, Andrulis IL, Lickley HL. Factors affecting distant disease-free survival for primary invasive breast cancer: use of a log-normal survival model. Annals of Surgical Oncology. 7: 416-26. PMID 10894137 DOI: 10.1007/s10434-000-0416-z |
0.343 |
|
| 2000 |
Khoo US, Ngan HY, Cheung AN, Chan KY, Lu J, Chan VW, Lau S, Andrulis IL, Ozcelik H. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Human Mutation. 16: 88-9. PMID 10874312 DOI: 10.1002/1098-1004(200007)16:1<88::Aid-Humu16>3.0.Co;2-G |
0.393 |
|
| 2000 |
Phillips KA, Andrulis IL, Goodwin PJ. Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 17: 3653-63. PMID 10550164 DOI: 10.1200/JCO.1999.17.11.3653 |
0.387 |
|
| 2000 |
Taylor MD, Gokgoz N, Andrulis I, Mainprize TG, Jun P, Drake J, Rutka JT. 720 A Novel Genetic Syndrome of Posterior Fossa Tumors of Infancy Secondary to Germline Mutation of hSNF5 Neurosurgery. 47: 505-505. DOI: 10.1097/00006123-200008000-00068 |
0.341 |
|
| 1999 |
Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF, Poon CS, Leung YF, Loong F, Ip P, Chan GS, ... Andrulis IL, et al. Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer. Oncogene. 18: 4643-6. PMID 10467410 DOI: 10.1038/Sj.Onc.1202847 |
0.682 |
|
| 1999 |
Phillips KA, Nichol K, Ozcelik H, Knight J, Done SJ, Goodwin PJ, Andrulis IL. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. Journal of the National Cancer Institute. 91: 469-73. PMID 10070948 DOI: 10.1093/Jnci/91.5.469 |
0.644 |
|
| 1998 |
Redston M, Nathanson KL, Yuan ZQ, Neuhausen SL, Satagopan J, Wong N, Yang D, Nafa D, Abrahamson J, Ozcelik H, Antin-Ozerkis D, Andrulis I, Daly M, Pinsky L, Schrag D, et al. The APCI1307K allele and breast cancer risk. Nature Genetics. 20: 13-4. PMID 9731522 DOI: 10.1038/1666 |
0.411 |
|
| 1998 |
To MD, Done SJ, Redston M, Andrulis IL. Analysis of mRNA from microdissected frozen tissue sections without RNA isolation. The American Journal of Pathology. 153: 47-51. PMID 9665464 DOI: 10.1016/S0002-9440(10)65544-7 |
0.532 |
|
| 1998 |
Ozçelik H, To MD, Couture J, Bull SB, Andrulis IL. Preferential allelic expression can lead to reduced expression of BRCA1 in sporadic breast cancers. International Journal of Cancer. Journal International Du Cancer. 77: 1-6. PMID 9639385 DOI: 10.1002/(Sici)1097-0215(19980703)77:1<1::Aid-Ijc1>3.0.Co;2-Y |
0.454 |
|
| 1998 |
Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KP, Hartwick RW, Hanna W, Lickley L, Wilkinson R, Qizilbash A, Ambus U, Lipa M, Weizel H, et al. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 16: 1340-9. PMID 9552035 DOI: 10.1200/JCO.1998.16.4.1340 |
0.393 |
|
| 1998 |
De Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, ... Andrulis I, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma Journal of Clinical Oncology. 16: 1248-1255. PMID 9552022 DOI: 10.1200/Jco.1998.16.4.1248 |
0.314 |
|
| 1998 |
Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL. p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias. Cancer Research. 58: 785-9. PMID 9485035 |
0.616 |
|
| 1995 |
Mousses S, Ozçelik H, Lee PD, Malkin D, Bull SB, Andrulis IL. Two variants of the CIP1/WAF1 gene occur together and are associated with human cancer. Human Molecular Genetics. 4: 1089-92. PMID 7655464 DOI: 10.1093/Hmg/4.6.1089 |
0.337 |
|
| 1994 |
Warner E, Medley D, Myers R, Andrulis I, Hosang AM. Dexverapamil (DEX) can reverse multidrug resistance (MDR) in breast cancer patients progressing on an anthracycline-containing regimen (ACR) Anti-Cancer Drugs. 5: 58. DOI: 10.1097/00001813-199409001-00133 |
0.436 |
|
| Show low-probability matches. |